CA1067892A - Iodo compounds - Google Patents

Iodo compounds

Info

Publication number
CA1067892A
CA1067892A CA229,909A CA229909A CA1067892A CA 1067892 A CA1067892 A CA 1067892A CA 229909 A CA229909 A CA 229909A CA 1067892 A CA1067892 A CA 1067892A
Authority
CA
Canada
Prior art keywords
methyl
iodocepham
phenoxyacetamido
carboxylate
ene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA229,909A
Other languages
French (fr)
Inventor
Robert B. Morin
Ronald G. Micetich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Connlab Holdings Ltd
Original Assignee
Connlab Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Connlab Holdings Ltd filed Critical Connlab Holdings Ltd
Priority to CA229,909A priority Critical patent/CA1067892A/en
Priority to SE7601704A priority patent/SE7601704L/en
Priority to NL7602157A priority patent/NL7602157A/en
Priority to DE19762608969 priority patent/DE2608969A1/en
Priority to FI760640A priority patent/FI760640A/fi
Priority to DK144576A priority patent/DK144576A/en
Priority to AT268476A priority patent/AT343807B/en
Priority to NO761353A priority patent/NO761353L/no
Priority to GB20744/76A priority patent/GB1545251A/en
Priority to FR7618804A priority patent/FR2315505A1/en
Priority to CH796176A priority patent/CH619231A5/en
Priority to JP51073772A priority patent/JPS525792A/en
Priority to BE168197A priority patent/BE843278A/en
Application granted granted Critical
Publication of CA1067892A publication Critical patent/CA1067892A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C07D205/095Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

ABSTRACT OF THE DISCLOSURE

There is provided compounds of the formula:

1 wherein R stands for benzyl, phenoxymethyl, 4-amino-4-carboxy-1-butyl, .alpha.-aminobenzyl and protected derivatives thereof, lower alkyl, aryl and heteroaryl, R3O-, R3S-, R3R4N- wherein R3 is lower alkyl, phenyl, or phenylloweralkyl, R4 is hydrogen or R3; R1 is hydrogen or a cleavable radical lower alkyl, 2,2,2-trichloroethyl, benzyl, p-nitrobenzyl, benzhydryl, phenacyl, or trimethylsilyl, and R2 is hydrogen or methoxy.
These compounds possess antibiotic activity and are also useful in preparing known penicillins and cephalosporins.

Description

1~E;78~
; PRIOR ART

Known commerical cephalosporins such as cephalexin, cephaloglycin, cephaloridine, cephalothin, cefazolin, and cephapirin are obtained by a number of dif-ferent processes, which also involve preparing a variety of intermediates for the respective cephalosporins.
Cephalosporin C and desacetoxycephalosporin C can be obtained by fermentation processes. The aminoadipyl moiety in these compounds is removed by various chemical processess to give 7-aminocephalosporanic acid (7-ACA) and 7-aminodes-acetoxycephalosporanic acid (7-ACDA) respectively. These basic compounds are then reacylated to introduce the appro-priate group. In most instances, further chemical modification of the molecule is necessary to provide the desired antibiotic.
The disadvantage of this route is t;he realtive difficulty and consequent high cost of preparing and isolating cephalosporin C and desacetoxycephalosporin C. As a result, alternate methods have been investigated~
Another approach makes use of the readily available, low cost, commerical penicillins G and V as starting materials.
Cephalexin, a commercially important cephalosporin, is manu~
factured by a multi-stage process starting from penicillin V, the process employed being illustrative of this method.
Penicillin V is converted to its sulfoxide which is rearranged under appropriate conditions to the cephalosporin. The cephalosporin is then deacylated to 7-ADCA or its ester, and reacylated by a variety of described processes to cephalexin.
The necessity to protect and later deprotect the amine and/or acid functions during some of these operations adds to the number of stages and hence to the cost of this process.

~.

9'~
A useful alternate approach is to react the penicillin sulfoxide with a mercaptan when an azetidinone-disulfide is obtained. Analagous sulfenamides are obtained by heating the sulfoxide in the presence o~ a silylated amide, or by treating the uns~m-azetidinonedisulfide with a suitable amine. These compounds on chlorination or bromination by various reagents produce the 2~chloro- (or bromo~ methylpenam or the 3-chloro- (or bromo-~cephams the compounds being inter-convertible. These 3-chloro- (or bromo-)cephams are also prepared ei$her by heating a penicillin sul~oxide in the presence of a chloride or bromide salt, or ~rom the 3-hydroxy~
cepham. The chloro- or bromo- cephams can be dehydrohalogen-ated to the respective cephems by methods described in the literature, and these cephems in turn deacylated by known ~ processes to 7-~DCA and its derivatives, which are the ; startiLg materials for certain commercial cephalosporins.
Un~ortunately, when proceeding to the dehydrohalogen-ation oi' the known 3-chloro- or 3 bromo- cephams, the biologi-cally inactive ~ -cephems are also ~ormed and this will involve either conversion o~ the ~2-cephem to the active ~3-cephem by a series o~ reactions, thereby increasing the cost o~ the desirable ~3-cephems or separation o~ the Q2_ and ~3 mixture has to be carried out which will also cause a decrease in yield.
Accordingly it would be highly desirable to produce a halogenated cepham derivative which would overcome the drawbacks oi the prlor art 3~chloro- or 3-bromo- cephams.

'?~
THE INVENTION
:
In accordance with the present invention, there is now provided the novel compounds, the 3-iodocephams or 2-iodo-methylpenams which have been d~r.i~ed from the 1,2,4-dithiaz-3-eneazetidinones 2, the thiazol-2-eneazetidinones 3, the ~y~-azetidinone disulfides 4, the unsym-azetidinone disulfides or azetidinone sul~onamides 5, by a novel process.
The novel compounds of the present invention are the 3-iodocephams or 2-iodomethylpenams corresponding to the general formula:

RCON ~ I . ~ < CH2I

~' 13 'COOR
: H COOR
1 lA

wherein R stands for benzyl, phenoxymethyl, 4-amino-4-carboxy-l-butyl and suitably protected drivatives thereof, a-amino-benzyl and protected de.~ivatives thereof, lower alkyl, aryl, heteroaryl, and R30-, R3S-, R3R4N- wherein R3 is lower alkyl, aryl, or arylloweralkyl and R4 is hydrogen or R3; R2 is hydro-gen or methoxy; and Rl is hydrogen or a cleavable radical such as -CH20CH3, lower alkyl, 2,2,2-trichloroethyl, benzyl, p~
nitrobenzyl, benzhydryl, phenacyl or trimethylsilyl.
Due to the fact that it is known that certain 3-halocephams are readily converted to the 2-halomethylpenams, it is intended herein that the novel 3-iodocephams 1 disclosed and claimed herein also include their isomeric ~orms which are the 2-iodomethylpenams lA obtained in accordance with the above illustration.

'7892 It is immaterial whether the cephams 1 or penams lA
are used as the starting materials. Further, it is difficult to distinguish between the structures and stereochemistries of the isomeric penams and cephams~ The structural assignment of the 3-iodocephams, 1 herein is made mainly from the close ressemblance of the nmr spectra of these compounds ~obtained under identical conditions) with the corresponding spectra of the respective 3-chlorocepham and 3-bromocepham, and the difference from that of the spectra of the 2~chloromethYlPenam and the 2-bromomethylpenam. It should, however, be noted that the 3-iodocephams and the 2-iodomethylpenams are to be considered as synonymous.
Generally, the novel 3-iodocephams 1 of the present invention are prepared by iodinating either the 1,2,4-dithiaz-3-eneazetidinones 2, the thiazol-2-eneazetidinones 3, the sym-azetidinone disulfides 4 or the unsym-azetidinone disulfides or azetidinone sulfenamides 5 in a suitable inert solvent and preferably in the presence of moisture~ These various reactions are schematically illustrated in Flowsheet I:

~67~

U~

8 ^ ~ 'D o el ~ C~ ~
' ~ \ ~

X

~1 \ . /

o~
0~1 1 ~
~ ~ / 8 a~
V ~ O

~ z o 3L~678~'~

In Flowsheet I the values of R, Rl, and R , are as defined previously, while X stands for S, R5 stands for lower alkyl; -(CH2)nCOO-lower alkyl where n is an integer of from 1 to 3, phenyl, heteroaryl and the group -C~7 where R6 stands for lower alkyl, phenyl, heteroaryl, -O-lower alkyl, -O-phenyl, -S-lower alkyl, -S-phenyl, or NHR8, and R and R
may be the same or different and each taken from the group H, lower alkyl, phenyl or heteroaryl.
As iodinating agent there may be used iodine, an iodinating agent such as N-iodosuccinimide or sulfenyl iodides, or mixture thereof. Depending on the starting compound, the amount of iodine is at least one mole equivalent or at least one atomic equivalent. When starting with the unsym-azetidinones 5, iodine is the preferred iodinating agent.
As iodine generating compounds there is preferably used sulfenyl iodides and iodine whereby near quantitive yields of 3-iodocephams 1 or 2-iodomethylpenams lA are obtain-ed. In certain cases optimum yields are obtained in presence of moisture. The sulfenyl iodide is best prepared in situ by the action of iodine on a mercaptan such as for example a lower alkyl mercaptan, an aryl mercaptan such as phenyl mercaptan, a heteroaryl mercaptan such as 2-mercaptobenzo-thiazole, an arylloweralkyl mercaptan such as benzyl mercaptan or a disulfide such as ~ 2-benzothiazole disulfide or benzyl, disulfide, a thioamide such as thioacetamide or thiobenzamide thiourea or a thioacid such as thioacetic acid or thiobenzoic acid, in a suitable inert solvent such as carbon tetrachloride, methylene chloride or chloroform. The sulfur compound-iodine-water system is thus preferred when having the azetidinones
2, 3 or 4 as starting compounds, since under these conditions near quantitative yields are obtained. Nevertheless it should ~06~8~2 also be appreciated that the nature o~ the substituent R
group and the nature of the sulfenyl compound will effect the yield. Thus, for example, when R is phenoxymethyl in azetidinone 2 or 3, near quantitative yields result when using certain sulfenyl iodides such as benzothiazole-2-sulfenyl iodide in the presence of moisture, while when R is phenoxy, low yields ~f the order of 5 to 30% are obtained with these same sulfenyl iodides and otherwise identical conditions.
The stoichiometry is again of importance when better yields are desired, Thus, compounds 2 or 3 with a mercaptan, thioamide or acid (1.5 mole equivalent) or a disulfide (Q~8 mole equivalent) and iodine (3 mole equivalent) give near quantitative yields of compound 1, while with compound 4, 3 mole equivalent of the mercaptan and 6 mole equivalent o~
iodine are preferable.
Also when using the unsym--compounds 5 as starting compounds the reaction proceeds smoothly and in excellent yields at ambient temperature and the stoichiometry does not appear to be important. Thus, reactions using an atomic equivalent or a molar equivalent of iodine gave essentially the same yields of over 90% and thus are preferred.
The iodination reaction is preferably carried out at room temperature and the reaction time is from 5 to 30 hours~
The moisture necessary in certain cases is preferably intro-duced by bubbling moist air through the reaction mi~ture while stirring, or by stirring the reaction mixture with water.
As suitable solvents, there may be used dioxane, tetrahydrofuran, ethyl acetate, methylene chloride, aceto-nitrile, and similar solvents.

10~7~9;Z

The preparation o~ the 1,2,4-dithiaz-3-eneazetidi-nones 2 is described in Can~ Appl. Ser. No. 208,248, filed Aug.
30, 1974. The preparation of thiazol-2-eneazetidinones 3 is described in U.S.P~ 3,594,389, July 10, 1971 while the sym-azetldinone disulfides 4 are obtained ~rom azetidinone di-sulfide as described in Tetra.Letters, 3001(1973) T. Kamiya ~t ; al.
The unsym-azetidinone disulfides 5 are obtained by heating a penicillin sulfoxide (either the ~- or ~sulfoxides or a mixture thereof) of the formula:

RCON ~ S
N

EI
with a mercaptan (Tetra.Letters, 3001(1~73~ T~ Kamiya et al) or with a thioamide of the formula:

R6-~-NHR7 ; where R6 and R7 are as previously defined. The reaction is carried out in the presence o~ a suitable solvent such as for example dioxane or toluene. As an example of suitable thio-amides, there may be mentioned thioacetamide,thiourea, thio-semicarbazide, thiocarbamate and dithiocarbamate~
In the case o~ the 1,2,4-dithiaz-3-eneazetidinones
3, it is not necessary to isolate the compounds 3, so that a simpli~ication o~ the process is possible, starting from the penicillin sul~oxide thioamide.

With an atomic equivalent o~ iodine and otherwise identical conditions, the 1,2,4-dithiaz-3-eneazetidinones 2, or the thiazol-2-eneazetidinone 3, are converted in high yields to the ~ azetidinone disulfides 4. This procedure constitutes a new process i'or the preparation o~ compounds 4.
The 3-iodocephams were ~ound to b~ stable and besides the obvious advantages o~ high yields (usually over 90%3 and simple reaction conditions, were found to be particularly suitable in certain reactions. Thus, ~or example, an attempt to prepare the bromo-compound by reacting the disulfide 5, (Flowsheet II) with bromine under controlled conditions was unsuccessful. The reaction with iodine, on the other hand, gave good yields o~ the 3-iodocepham, 1, (Flowsheet II~.
Another advantage in the use o~ the 3-iodocephams is their rapid and facile dehydroiodination in the presence of a base such as pyridine, to the 3-cephem. As a result, the yields in this stage are also high, and complications such as the possible co-i'ormation o~ the bioinactive 2-cephem are minimized and almost non~existent.
Illustrative of the advantages o~ the use of the 3-iodocephams, are the processes summarized in Flowsheets II
and III in which the readily available, comparatively cheap, commercial ampicillin and penicillin V are conveniently con-verted to cephalexin and 7-phenoxyacetamido-3-methylceph-3-em-4-carboxylic acid respectively, As illustrated by Flowsheet II, ampicillin 6 was converted to ampicillin sul~oxide 7~ This compound when treated with chloromethylmethylether and triethylamine in the presence o~ carbon dioxide, gave the diprotected ampicillin sulfoxide 8, in one step. Heating compound 8 with a mercaptaa such as benzothiazole-2-thiol in dioxane for 16 hours gave a near quantitative yield of the unsym-azetidinone disulfide 5, 30 which on iodination with iodine ln methylene chloride gave the -3-iodocepham 1. Dehydro-iodination of 1 with pyridine, followed by deprotection by acid (trifluoroacetic acid) gave cephalexin 9, isolated as its trifluoroacetate salt. Free cephalexin could be obtained from the salt by neutralization or by the use of an ion-exchange resin.
~ lowsheet III illustrates a similar conversion of penicillin V, lO, to 7-phenoxyacetamido-3-methylceph-3-em-4-carbo~ylic acid, 12. Penicillin V, lO, was converted to penicillin V sulfoxide, 11, which could be used as such, or optionally converted to an ester such as the methoxymethyl-ester. Compound 11 on heating with a suitable mercaptan, such as benzothiazole-2-thiol, was converted to the unsym-azeti-dinone disulfides, 5, in excellent yeilds. Iodination gave the 3-iodocephams, 1. In the case of the free acid, silyation was desirable for the iodination reaction, for reasons of solubility, the silyl group being removed during the work-up process. Dehydroiodination of 1 provides compound 12.
The processes can be further simplified by super-imposing the reactions in the same pot. It will be obvious to one skilled in the art that various other modifications o~
this process are possible for the conversion, for example of ampicillin to cephalexin; 6-APA to 6-ADCA;carbenicillin, ~-sulfobenzylpenicillin and 6-mandelamidopenicillin to the respective cephalosporins;and the 6-methoxypenicillins to the 7-methoxycephalosporins. Another advantage is that the novel 3-iodocephams and 2-iodomethylpenams can be converted to various 3-substituted cephams and 2-substituted methylpenams with side chains ~such as D-phenylglycyl) which are known to confer enhanced activities; compounds which otherwise are difficult to prepare.

-9z The 3-iodocephams show antibiotic activity~ Thus, 7-phenoxyacetamido-3-methyl_3-iodocepham-4-carboxylic acid, 1 (R = 0OCH2, R1 = H, R2 = H) is active against Bacillus subtilis NCIB 8057. This acid also shows the following activity compared to 7-phenoxyacetamido-3-methylceph-3-em-4-carboxylic acid.
(MIC in ~g/lm) Staph.aureus S. lutea 7-phenoxyacetamido-3-methyl ceph-3-em-4-carboxylic acid 0.254 1.01 Iodocepham acid 0.254 0.507 It should also be appreciated that the 3-iodocephams, 1, are useful intermediates for the preparation of cephalo-sporins. For example, on treatment with bases such as pyridine and collidine, they undergo a facile dehydroiodination to provide the cephems. The cephems thus obtained can be deacylated by known procedures to the 7-ADCA deri~atives and ; these compounds may in turn be converted by processes described in the literature to the commercially important cephalexin.

FLOWSH~~ET II -~ ~ m Conversion of Am~c;Lllin to Cephaloxin CHCONH
~:~ NH ~ S ~ Amplcilli~

COOH

CHCON ~ S
NH2~ -Ampic~ n Sulfoxide `~

CO H
/C2/clcH2clcH3 CHCONH ~ S ~ "Protected"
N V ~ Ampicillin Sulfoxide CoocH2ocH3 COocH20cH3 `~

CHCO~H ~ S- S - R ~ Azetidlnone D1sulfide H o~ N ~
~` COOCH20CH3 CoOcH20cH3 CHCONH~. ~ S -~
- - I ~ 3-Iodocepham : :
:~ NH ~ N ~
COOCH2C 3 ~ h -HY
. ~ICHCONH ~ S . :~
NH2 ~ N ~ ~ ~ephalexin : COOH
, l Z ~
, - :~0~ii789Z - - ~

~ FLOWSHEET II.I
. . - , . . , . - :
, . . . i , : . - .
.~: Conversion of Penicillin V to Desacetosycephalosporin V~

. ~OCH2CONH ,fS
. ~ ~ : : Penicillin V

COOH

OCH CON~ S
2 ~ : ~ : ~ Penicillin Sulfoxlde OCH2CONII S_S~
Unsym-Azetidinone Disulfide COOH (COOCH20CH3) - l. Silylation ; : - . ~ :2.: I2 :- - : - 3, Desilylation OCH2CONH ~ ~ , S~
I i I : . 3-Iodocepham - ~::
~- O - N ~ 3 COOH (COOCH20CH3) , , ~
l. Silyla*ion ~ : -. 2, -HI
3. Desilylation .
~OCH CON ~ S ~
2 ~ Desacetoxycephalosporin V
CH3 l2 COOH

.

, - '-'''' '", '''''~' 67~9~

.- ~ : -- EXAMPLES .
~- The present invention will be more readily understood~
.-~ by referring to the following Examples which are given only to : ~ illustrate the invention rather than limit its scope.

EXA~PLE 1 ~

- ~- Methyl 7-Phenoxyacetamido-3-Methyl-3-Iodocepham-4-Carbo~ylate-~ 1 (R =;~OCH2-, R2 - H, R~ CH3) from ~lethyl 6-Phenoxythloacet-:

.~` - ;. - amidopenicillanate Sulfoxide with Isolation of 2 (R~= ~OCH2-~

R2 - H, Rl = CU3 ~

. 10:.~ . A solution of pure methyl 6-phenoxythioacet-amidopeni- .
~ ` cillanate sulfoxide (503 mg, 1.3 mmoles) in toluene (~125 ml) `~ ~ was heated ~in an o11 bath:at 12() C) with stirring under re-- flux, under n:itrogen, in a.~lask fitted with a Dean-Stark trap~
. for 3~ hours. The toluene was removed in vacuo. An nmr s.pec-;
--trum (CDC13) of the waxy~residue:shoued complete reaction aDd:.

. -:
. -. formation of methyl 3-phenoxymathyl-4,5-dithia-2,7-di~abicy-~

: clo~4,2,0]oct-2-ene-8-one-7-isopropenylacetate, 2 (R = ~OCH2,~ :

R = ~ R = CH3) ~7.5 to 6.9(m,~ SH, C~5), 5.72(d with wings, : 2H, ~-lactam protons), 5.19 an.d~.O8(ds, 2H, ~ ), 4.95(s,`.
~.
20 : lH, CHCOOCH3), 4.87~s, 2H, -oc~ - ? 3.8(~, 3HI COOCH3), l.90(s~

~: CX3 ~ -The total residue was dissolved in purified dloxane and~
iodine (365 mg, 1.43 mmoles3 added~, the.mixtur.e was stirred and moist air obtained by bubbllng air throu~h water then passed through the solution A~ter lB ~ours the reaction mixture was concentrated to dryness and an nmr spectrum obtained on the residue. The dark bro-~m residue c~uld .he partially purified by taking up in ethyl acetat~ or~met;h~lene chloride or chloro-.

`- ~O~i7~39~2 form, washing with aqueous sodium thiosulfate and watsr, dry-ing over magnesium sulfate with added decolorising charcoai, and concentrating, when a pale yellow thick oil resulted. The nmr spectra of the crude material and the partially purified product showed the formation of about 35~ iodocepham, 1, which could be distinguished by the -CH2-S quartet at about ~3 and the=~cH singlet at about ~2.2. The presence of the iodo-cepham, 1, was confirmed by a thin layer chromatogram run with an authentic sample of 1 as reference.

EXAMPLE ~

Methyl 7-Phenoxyacetamido-3-Methyl-3-Iodocepham-4-Carboxylate, 1, (R = ~OCH2-, R = H, Rl = CH3) from Methyl 6-Phenoxythio-acetamidopenicillanate Sul~oxide without Isolation of 2 (R 8 ~OCH2, R2 = H, Rl ~ CH3~

A solution of pure methyl 6-phenoxythioace$amidopeni-cillanate sulfoxide (2 g., 5.2 mmoles) ln dioxane (500 ml) was heated with stirring under reflux in a nitrogen atmosphere, in an oil bath at 120 C for ~ hours. (Prior experiments had shown that these conditions gave a quantitative yield of the methyl 3-phenoxymethyl-4,5-dithia-2,7-diazabicyclo[4,2,0]oct-2-ene-8-one-7-isopropenylacetate, 2.) The reaction mixture was cooled to ambient temperature, iodine (1.52 g., 6 mmoles) was added and moist air bubbled through the stirred solution at ambient temperature for 16 hours. The reaction mixture was then taken to dryness, the residue taken up in methylene chlor-ide, washed with aqueous sodium thiosulfate and water and dried over magnesium sul~ate with decolorising charcoai. The nmr spectrum oi thi~ Yoam indicated the presence oi ~bout 20~ oi the 3-iodocepham, 1 ~ 15 -67893;~
The crude product (1 g.) was purified by gradient elu-tion chromatography on silica (Mallinckrodt Silicar CC-7) using ether:hexane = 3:1 ~ ether as the eluants. The pure 3-iodo-cepham (100 mg.) was thus obtained as an amorphous faint yel-low solid and was identical (ir and nmr spectra and tlc) to an authentic sample prepared by the alternate route (see Example 17). The nmr spectrum (CDC13) ~7.85 to 6.92( m, 6H, C5H5 and NH), 5.88 and 5.7(dd, lH, J = 4c/s, C7-H), 5.42(d, lH, J =
4c/s, C6-H), ~.95(s, lH, C4-H), 4.7(s, 2H, -O-CH2-), 3-85(s, 3H, COOCH3), 2.98(ABq, 2H, J = 15c/s, C2-CH2), 2.22(s, 3H, C3-CH3) is quite charactsristic of these co~pounds.
In a similar manner using trimethylsilyl 3-phenoxymethyl~
4,5-dithia-2,7-diazabicyclo[4,2,0]oct-2-ene-8-one-7-isopropen-ylacetate, methoxymethyl 3-phenoxymethyl-4,5-dithia-2,7-biazabicyclol4,2, O]oct-2-ene-8-one-7-isopropenylacetate, trichloroethyl 3-phenoxymethyl-4,5-dithia-2,7-diazabicyclo~4,2, O~oct-2-ene-B-one-7-isopropenyl acetate, trimethylsilyl 3-phenoxy-4,5-dithia-2,7-diazabicyclo~4,2,0~oct-2-ene-8-one-7-isopropenyl acetate, methoxymethyl 3-phenoxy-4,5-dithia-2,7-diazabicyclo[4,2,0]oct-2-ene-8-one-7-isopropenyl acetate, methyl 3-methylthio-4,5-dithia-2,7-diazabicyclo[4,2,0~oct-2-ene-8-one-7-isopropenyl acetate, methoxymethyl 3-methylthio-4~5-dithia-2~7-diazabicyclo[4~2 oct-2-ene-8-one-7-isopropenyl acetate, trimethylsilyl 3-methylthio-4~5-dithia-2~7-diazabicyclo~4l2~oJ
oct-2-ene-8-one-7-isopropenyl acetate, benzyhydryl 3-phenylthio-4,5-dithia-2,7-diazabicyclo[4,2,01-oct-2-ene-8-one-7-isopropenyl acetate, methyl 3-phenylthio-4,5-dithia-2,7-diazabicyclol4,2,01oct-2-ene-8-one-7-isopropenyl acetate, - : :
r ~ 7 89;~ ~
- .

.; ~ methoxymethyl 3-phenylthio-4,5-dithia-2,7-diazabicyclo[4,2,0oct-2-ene-8-one-7-isopropenyl acetate,~
trimethylsilyl 3-phenylthio-4,5-dithia-2,7-diazablcyclo[4,2,0 oct-2-ene-8-one-7-isopropenyl acetate~
:: - . - - ~ ~ :
--~ : trichloroethyl 3-benzyl-4,5-d.ithia-2,7-diazabicyclo~4,2,0~-::. oct-2-ene-8-one-7-isopropenyl acetate, it is possible to obtain`
the followlne compounds~
7-phenoxyacetamido-3-methy1-3-iodocepham-4-carboxylic acid, ~.
.methoxymethyl 7-phenoxyacetamido-3-methyl-3-iodocepham-4-car-10~ boxylate, 1 ~ : trichloroethyl 7-phenoxyacetamido-3-methyl-3-iodocepham-4-car- ::-. boxylate, .:7-phenoxyamido-3-methyl-3-iodocepham-4-carboxylic acid, . .
,: . :. . . . . ................................................. .
methoxymethyl 7-phenoxyamido-3-methyl-3-iodocepham-4-carboxy-- late 1: ' . methyl 7-methyIthiolcarbamido-3-methyl-3-iodoceph~m~4-carboxy-.-methoxymethyl 7-methyl~hiolcarbamido-3-methyl-3-iodocepham-4-carboxylate, 7-methylthiolcarbamido-3-methyl-3-iodocepham-4-carboxylic àcld,~
benzhydryl 7-phenylthiolcarbamido-3-methyl-3-iodocepham-4-car-- : . . . . . .
. - -`. boxylate, , methyl 7-phenylthiolcarbamido-3-methyl-3-iodocepham-4-carboxy-late, metho.Yymethyl 7-phenylthiolcarbamido-3-methyl-3-iodocepham-4-carboxylate, 7-phenylthiolcarbamido-3-methyl-3-iodocepham-4-carboxylic, and trichloroethyl 7-phenylacetamido-3-methyl-3-iodocepham-4-car- .
boxylate. ~ . ~
, ' - - r~.

EXA~IPLE 3 - - -Preparation o~ 3-Phenoxy-4,5-Dithia-2, 7-Diazabicvclo 14 . 2, 01 Oct-2-Ene-8-One-7-Isopropenylacetic Acid, 2 (R = ~0, R2 = H, Rl =H~

solution of~ 6-phenoxythlocarbamidopenicillanic acid:
sulfoxide'(15 g., O.04 mole) in purified dioxane (300 mls) was~
heated with stirring under re~'lux in a dry nitrogen atmosphere~
' ;in an oil bath maintained at 130 ,~for 4 hours. The,reaction ' ~' mixture was concentrated in vacuo and dried under hi-vac. The '~
yellowish brown solid thus obt~alned was dlssolved in the mini-~mum amount of warm acetone, the solution treated with charcoa?,'~ -and filtered. The filtrate was concentrated to about 1/3 its volume and just sufficient hexane added to induce crystallisa~
tion. The mixture was'cooled overnight~ at about -10 and the~-resulting pale yellow crystals isolated by filtration and dry- `
ing, when 10.5 g (75%) of 3-phenoxy-4,5-dithia-2,7-diazabicy-clot4,2,0]oct-2-ene-8-onc-7-isopropenylacetic acid was obtained.
;The compound could be purified by recrystalllsation from ace-tone-hexane. It was obtained as white crystals,m.p. 146-148 dec.~ A high resolution mass spectral analysis gave a mass of ;-~350.0404 for the parent ion, that calculated for C15H14N2S
being 850.0396. The nmr (D~SOd6)spectrum ~7.~8 to 7.15(m, 6H,~
C6H5 and COOH), 5.87 and 5.53(A q,~2H, J = Sc/s, B-lactam pro-~tons'cis fused), 5.2(s, 2H, ~ ),- 4.85(s, lH, -CHCOOH), 1.89(s, 3H, ~ CH ) is'in agreement with the assignment.

.
- - . :

EXA~.IPLE 4 :: :
' Preparation of ~Icthvl 8-Phenoxy-4,5-~ithia-2,7-Diazabicyclo~4,`~

2,0]0ct-2-Ene-8-One-7-Isopropenyl Acetate,2,(R=~O,R2=H,Rl=CI~3) J. . ~:
' ' 3-Phenoxy-4,5-dithia-2,7-diazabicyclo~4,2,0]oct-2-ene-8-one-7-isopropenyl~cetic acid (10.0 g., 28.5 mmole) was dis- ~' - t8 -- :'''~

678~Z

- solved in tetrahydrofuran (~50 ml~ and the solution cooled la an ice-bath. Diazomethane in ether~'(100 ml-excess) was added' and the solution stirred ln the ice-bnth for 0.5 hours and .then . ~ . -~ : concentrated in vacuo. The residue was taken up in the minimum -o~ ether and cooled in a dry ice-ace~one bath while adding an -. . ~ equal volume of hexane. The resulting white precipitate was -: ~ ~' filtered off and dried to give ~.0 g~of the product, m~.'p. 79-. - O ~ -' 82 C. A further 1.5 g was obtained from the mother liquor after concentratlon and repeating.the ether-he~ane precipita-~- 10 tion. The two crops were combined (~.5 g, 81~o) since.:they were ~ ~ identical (nmr spectra and tlc). 'The nmr(CDCl ) spectrum: ~7.6' . : . 3 . ... .
to 7.1(m, 5H, C6H5), 5.7 and 5.48(ABq, ~H, J=4c/s, ~-lactam ~ ~' ' '' protons cis-fused), 5.22 and 5.12(d, s, 2H,-~CH2), 5.0(s, lH, ~' . ' '~CHCOOCX3), 3.8(s, 3H, COOCH3~ and 1.97(s, 3H ~ ) was in ' CH3 . ' agreement with the assigned structure. A.high resolution mass spectral analysls gave a mass of 364.0565 for the parent ion', tha~ calculated for C16H16N ~2 4 being 3~4.0552. ~ ~' - . EXA~IPLE 5 '~ ....~ . - - .

- ' :Methyl 7-Phenoxyamido-3-~lethyl-3-Iodocepham-4-Carhoxylate, 1, : 20 (R = ~0, R2 = H, Rl = CH3) Using ~5ethylene Chloridè~

~ethyl 3-phenoxy-4,5-dithia-2,7-diazabicyclo[4,2,0]oct-2-ene-8-one-7-isopropenyl acetate (2.0 g, 0.005 mole) was dis-.
solved in purified methylene chloride (50 ml) and iodine(l.4 g,.
0.0055 mole) added. The reaction mixture was stirred at room temperature for 20 hours, concentrated, the residue taken up-in dioxane and reacted with moist air for 16 hours, then concen-trated and redissolved in methylene chloride.' The resultin~
solution was extracted with aqueous sodium thiosulfate (t~vice) , and then water (twice). The organic phase was dried with mag-ncsium suifate and charcoal, filt~red and concentrated to ~iYe - 19 -.
. .

' '` - - ~01~789Z~

.
9 g of a yellow foam whose nmr spectrum indicated the~pres-. ence c~ about 22% of the 3-iodocepham, 1. This was confirmed .. ~ . . , : by a tlc using an authentic sample of 1 prepared by the altèr--nate route (see Example 34).-ethyl 7-Phenoxyamido-3-Methyl-3-Iodocepham-4-Carboxylate, 1 - : . . . . . . .
(R = ~O-, R2 = H, Rl - CH3) Using Ethyl Acetate - . :

When purified ethyl acetate was used as solvent under the same conditions as in~Example 5, a 30% yie1d of the 3-1odo-cepham as estimated from the nmr spectrum was realised.

:Methyl 7-Phenoxyamido-3-Methyl-3-Iodocepham-4-Carbo~ylate, 1, ~(R~= ~O-, R2 = H, R3 = CH3) Using Dioxane When purified dioxane was used as solvent:under : ~ the same conditions as in Example~5:, a: 257c yield of the 3-iodocepham as estimated from the nmr spectrum was:realised.

~ : : . EXAMPLE 8 - -~

- : Methyl 7-Phenoxyamido 3-Methyl-3-Iodocepham-4 Carboxylate, 1, - ~
(R = ~O-, R2 = H, R3 = CH3) Using Tetrahydrofuran : 20 When purified tetrahydrofuran was used.as solvent under the same conditions as in Example 5, a 12.5~o yleld 0~ the 3-iodocepham as estlmated from the nmr spectrum was reallsed.
- '' ' '' ~ '':

': :
. - 20 ~ :

- ~ ~
671~92 : - -- - - . . :
- ~ EXA~IPLE 9 ;

~ (Methyl 3-Phenoxyacetamidoazetidinone-l-Isopropenyl Acetate~ :~
.
-4-Disulfide,4, (R = ~OCH2-, R2~- H, Rl = CH3) from ~ethyl 3-, . ~
Phenoxymethvl-4,5-Dithia-2,7-Diaæabicyclo[4 2,0]0ct-2-Ene-3-One-~~ 7-Isopropenylacetate, 2 (R = ~OCH2-, R2 = H, Rl-= CH3) - ~ llethyl 6-phenoxythioacetamidopenicillanate sulfoxide - -: ~ : . :: .
(1.0 g, 2.6~mmoles) was converted to methyl 3-phenoxymethyl-4,5-- dithià-2,7-diazabicyclo[4,2,0]oct-2-ene-8-one-7-isopropenyl-- acetate, 2 (R = ~OCH2-, R = U, Rl = CH3) as~descrlbed in Ex-~
` 10 ample 1. The total residue from the thermol~sis in toluene was-dissolved in purified dioxane (500 mls), iodine~(330 mg., : . - --- :
1.3~mmoles) added and moist air bubbled through the stirred - solution at ambient temperature for 20 hours. The-solution - was concentrated, *he residùe dissolved in methylene chloride ~ `
- - a~d the resulting solution washed with aqueous sodium thio-sulfate (twlce) and water (tulce), drled over magnès1um sul-fate and charcoal, and concentrated. The resuIting yellow ~
foam ~eighed O.9 g (94~0) and was the ~ azetidinone, 4 (R =
- . ~ .
~ OCH2-, R = H, R = CH3). The nmr (CDC13) spectrum ~7.8(d, lH, ; 20 ( . , C6H5), 5.52 to 5.37(m, 2H,~ ~-lactam protons), 5.22 and 5.1(brs, s, 2H, -~ 2), 4.9(s, lH,CHCOOCH3), 4.6(s, 2H, -O-CH2), 3.75(s, 3H, COOCH3), i.91(s, 3H, ~ CH ) was consistent with the assigned structure.
, - EXA~.IPLE 10 lethyl 3-Phenoxyacetamidoazetidinone~l-Isopropenyl Acetate) -4-Disulfide, 4 (R = ~OCH~-, R = H, Rl = CH3) from ~lethyl 3-Phenoxvmethvl-4-Thia-2,G-Diazabicyclo[3 2,0]Hept-2-Ene-~-One-6-Isopropenylacetate, 3 ~R = ~OCH2-, R2 = H, Rl = CH3) .

- 21 - ~ `

~_ ~INg¦~

6789Z - -- :
.
When methyl 3-phenoxymethyl-~-thia-2,6-diazabicyclo[3,2, ; :.- OJhept-2-ene-7-one-6-isopropenylacetate, 3, (R =~OCH2-;, B2~=H, l = CH3) (100 mg, 0.29 mmoles) was treated with an atomic ~:. equival-ent (40 mg, 0.15 mmoles) of iodine in dioxane (100 mls) .
in the same way as described in Example 9, the same:product 4 (R = ~OCH2-, R2 = H, Rl = CH3) was obtalned. The~nmr spectrum~
~:: . was identical to that o~ the product in E~ample 9.

EXA~IPLE ll~

ethyl 7-Phenoxyacetamido-3-Methyl-3-Iodocepham-4-Carboxylate,l -.10 (R = ~OCH2-, R2= H, Rl= CH3) from Methyl 3-Phenoxymethyl-4-~

:Thia-2,6-Diazabicyclo[3,2,0~ ept-2-Ene-7-One-6-Is~opropenylace-: .; . ~ tate, 3, (R - ~OCH2-,~R2 = H, Rl = CH3)~

~ ;hen methyl 3-phenoxyme~thyl-4-thia-2,6-diazabicyclo[3,2:, : : - 2 . ..O]hept-2-ene-7-one-6-isopropenylacetate, 3 (R - ~OCH2-, R. = H., l = CH3) was treated with at least one molnr equivalent of - , . .
.iodine in dioxane by the same process as described in Example~-l -the nmr spectrum of the~product~:showed the presence of about~

.25~o 0f: the 3-iodocepham,~

EXAMPLE l~

Methyl 7-Phenoxyacetamido-3 Methyl-3-Iodocepham-4-Carboxylate,l -: _ (R = ~OCH2-, R2 = H, Rl = CH3) from ~ ethyl 3-Phenoxyacet--amidoazetidinone-l-Isopropenylacetate)-~-Disulfide, 4 ~R = :.

~OCH2-, R = H, R1 = CH3j ..
.

. When sym(methyl 3-phenoxyacetamidoazetidinone-1-isopro- .
penylacetate)-4-disulfide, ~, (R = ~OCH2-, R2 = H, Rl z Cl13?
: , was treated with one molar equivalent of iodine in dioxane by the same process as described in Example 1, the nmr spectrum-- 22 - .
- - .

L0678gZ - ~
- ~ of the product showed the presence of about-20%.of the 3-iodo-:, . . - - ,; ~ ', - cepham, 1.
.
- .
EXA~PLE 13 ~- Methy1 7 Phenoxvacetamido-3-~ethvlce~h-3-em-4-CarboxYlate from :. - . :
Methyl 7-Phenoxyacetamido-3-~lethyl-3-Iodocepham-4-Carboxylate,l (R = ~OCH2-, R2 = H, R1 - CH3) A so~ution of methyl 7-phenoxyacetamido-3-methyl-3-iodocepham-4-carboxylate (250 mg,~ 0.5 mmole) in benzene (3 mls) ~ containing~pyridine(100 mg, 1.25~mmoles) was~heated under reflux t ~ 10 ~or l hr. Filtration and concentration gave~a quantitative yield of methyl`7-phenoxyacetamido-3-methy1-3-em-4-carboxy-late and the starting compound in a ratio of 3~:~ 1 respec~ively, .
~ as estimated from the nmr spectrum. The cephem producèd has a ., ~ , - ~
characteristic nmr spectrom with~signals àt ~7.8 to 6.9(C6H6);
- 5.97 and 5.8(dd, C7-H); 5.08(d, C6-H); 4.61(s~, O-CH2-)`; 3.88(s, COOCH3~); 3.4(d, C2-CH2) and 2.2(s, C3-CH3).~ Although most~of ` ~ these signals overlap with those of the 3-iodocepham, the ~-- - - ~ ~ ~
- cephem is easily identified by the doublet at 3. and the dis:lp-- - ~ pearance of the C4H singlet at 4.~5(present in the 3-iodocepham).

~ ~ ~ EXAMPLE 14 Methyl 7-Phenoxyacetamido-3-Methyl-3-Iodocepham-4-Carboxylate,l (R=~OCH2-, R2=H, Rl=CH3) from Methyl-3-Phenoxymethyl-4,5-Dithia~

- 2,7-Diazabicyclo[4,2,0]0ct-2-Ene-8-One-7-Isopropenylacetate, 2 (R= ~OCH2-, R2 =H, Rl =CH3) using Sulfenyl Iodides-Iodine-Water .
: - - , ~ .
- A mixture of methyl 3-phenoxymethyl-4,5-dithia-2,~
diazabicyclot4,2,0]oct-2-ene-8-one-7-isopropenylacetate(150 mg, 0.38 mmoles), thiourea(44 m~, 0.57 mmoles), and iodine(290 m~, - 23 - ~

.
-F

67~39Z
- ' : - ' - .. - :
1.14mmoles) in methylene chloride (10 ml) was stirred with water (I0 ml) at ambient temperature for 12~hrs. The or~anic laye~ -.~ - . . .
~ was dried over magnesium sulfate, ~iltered and concentrated.
- .
The nmr spectrum (CDC13) o~ the product indicated over 85~o of . . -. . :
the 3-iodocepham to be present.
- Exactly similar reactions were rùn using the following mercaptans in place of thlourea with the~results-indicated:
Sulfenyl Iodide Precursor ~-Yield of 3-iodocepham (~j ~ 2-~Sercaptobenzothiazole ~ 8S~
- 10 2-Mercaptobenzimidazole ~ 30 ; Triphenylmethylmercaptan ~ 30 p-Chlorothiophenol - - -~ 60 -~ Ethyl 2-mercaptoacetate ~ 30 ~ - 2-~lercaptothiazolene ~ 75 ;~ ~ Thioacetamide ~-50 - t-Butylmercaptan ~ 70 Besides the above, other mercaptans such as methyl, ethyl, isopropyl, phenyl and benzyl mercaptans; thioamides such ~: - , . . .
as benzamide, N,N'-dimethylthiourea and N,N'-diphenylthiourea;
- 20~ and thioacids such as thloacetlc~acid and thiobenzolc acid and disulfides such as methyl, benzyl, t-butyl and p-tolyl can also - be~used.
In a similar manner, using the thlo compounds such as those described above and .
methoxymethyl 3-phenoxymethyl-4,5-dithia-2,7-diazabicyclo[4,2, Oloct-2-ene-8-one-7-isopropenylacetate, ~ trichloroethyl 3-phenox~methyl 4,5-dithia-2,7-diazabicyclo[4,2, :
O]oct-2-ene-8-one-7-isopropenylacetate, - benzyl 3-phenoxymethyl-4,5-dithia-2,7-diazabicyclo[4,2,0]oct-2-ene-8-one-7-isopropenylacetate, p-nitrobenzyl 3-phenoxymethyl-4,5-dithia-2,7-diazabicyclo[4,2, O]oct-2-ene-8-one-7-isopropenylacetate, methoxymethyl 3-benzyl-4,5-dithia-2,7-diazabicyclo[4,2,0]oct-2-ene-8-one-7-isopropenylacetate, ... . . . , .. ._, .. .,, ,,~

- - - :1~67892 --- ~ . ' ., . - . . - .

- - trichloroethyl 3-benzyl-4,5-dithia-~,7-diazabicyclo~4,2,01oct-2-ene-8-vne-7-isopropenylacetate, ~. benzyl.3-benzyl-4,.5-dithia-2,7-diazabicyclo[4,~,0]oct-2-ene-8-.: one-7~isopropenylacetate -:. ben2hydryl 3-benzyl-4,5-dithia-2,7-diazabicyclo[4,2,0~oct-2-ene--:. .8-one-7-isopropenylacetate, and trichloroethyl l-methoxy-3-phenoxymethyl-4,5-dithia-2,7-diaza-bicy.clo[4,2,0]oct-~-ene-8-one-7-isopropenylacetate,.it is ; - ~ possible to prepare the~followlng compounds methoxymethyl 7-phenoxyacetamido-3-methyl-3-iodocepham-4-carbox-.ylate.~
:. - trichloroethyl 7-phenoxyacetamido-3-methyl-3-iodocepham-4-car-~ boxylate, : . ~ benzyl 7-phenoxyacetamido-3-methyl-3-iodocepham-4-carboxylate, .
. ~ : . - :
nitrobenzyl 7-phenoxyacetamido-3-methyl-3-iodocepham-4-car- .

. ; boxylate, methoxymethy-l 7-phenylacetamldo-3-methyl-3-1odocepham-4-car---boxylate, .~
- . . : - , .
"~ : . trichloroethyl 7-phenylacetamido-3-methyl-3-iodocepham-4-car- :

~ boxylate, - - benzyl 7-phenylacetamido-3-methyl-3-iodocepham-4-carboxylate~
, . . - ~ .
-~ . : benzhydryl 7-phenylacetamido-3-methyl-3-iodocepham-4-carboxylat~, -:and trichloroethyl 7-methoxy-7-phenoxyacetamido-3-methyl-3-iodoceph-am-4-carboxylate.

~ 25 ~

~ ~ , .~J - ~ ~6789 -. ~ E~AMPLE 15 . . . ; . . . ~,, Methyl 7-Phenoxyacetamido-3-Methyl-3-Iodocepham-~-Carboxylate,l (R = ~OCH2, R = H, R - CH3) from Methyl 3-Phenoxymethyl-4- ~

Thia-2,6-Diazablcyclot3,2,0]Hept-2-Ene-7-One-6-Isopropenylace- ~`

~` ~ tate, 3 (R = ~OCH2, R = H, Rl~=CH3) using Sulfenyl Iodides- `-, ~
- Iodine-~'Jater 2-~lercaptobenzothiazole (70.2 mg., O.42 mmoles)~and iodine (213 mg., 0.84 mmoles~ were added to a stirred solution of methyl 3-phenoxymethyl-4-thia-2,6-diazabicyclo[3,2,0~ hépt-2-ene~7-one-6-isopropenylacetate (lOO m~s.,0.28~mmoles) in~ --methylene chloride (15 ml), and the`mixture stlrred at ambient -~
temperature for 15 mins. Water (15 mls3 u~as then added and the ~-` ~ ~ mixture stirred-overnight at room temperature. ~The- organic layer was separated, dried over magnesium sulfate, filtered and ~concentrated. The nmr spectrum of the residue showed the pre-sence of about 80/~o of the 3-iodocepham.
- In a similar manner using the thio-compounds such as thioacetamide, thioacetanillde, thiourea, N,N'-dlmethylthiourea, N,N~-diphenylthiourea, t-butyl mercaptan, isopropylmercaptan, ~-- ~ 20 thiophenolj p-chlorothiophenol, ethyl 2-mercaptoacetate, 2-mer-~
- . . . -:j ~- captobenzooxazole, 2-mercaptobenzimidazole, 2-mercaptothiazol-ene, triphenylmethylmercaptan, benzylmercaptan, dimethyl disul-~
~ide, dibenzyldisulfide, di-t-butyldisulfide, di-~-tolyldisul-. . . .
~ide, thioacetic acid and thiobenzoic acid and the followin~
compounds;
trichloroethyl 3-phenoxymethyl-4-thia-2,6-diazabicyclot3,2,01-. .
hept-2-ene-7-one-6-isopropenylacetate, ~-nitrobenzyl 3-phenoxymethyl-4-thia-2,6-diæzabicyclo[3,2,0]-hept-2-ene-7-one-6-isopropenylacetate, ~30 trichloroethyl 3-benzyl-4-thia-2,6-diazabicyclol3,2,0~hept-2-~ne-7-one-6-isopropenylacetate, .,, , ' . ' ~

- 1~)678~
~-nitrobenzyl 3-benzyl-4-thia-2,6-diazabicyclo[3,2,0]hept-2- - ' : , " ~ ~
- -ene-7-one-6-isopropenylacetate, and trichloroethyl l-methoxy-3-phenoxymethyl-4-~hia-2,6-diazabicyclo-' ~; , . . ~ ,, .:
' ' t3,2,0]hept-2-ene-7-one-6-isopropenylacetàte,' ,, it is possIble to obtain;
- trichloroethyl 7-phenoxyacetamido-3-me*hyl-3-iodocepham-4-car-. : - - . . , - :
boxylate, p-nitrobenzyl 7-phenoxyàcetamido-3-methyl-3-iodocepham-4-car-boxylate, trichloroethyl ~-phenylacetamido-3-methyI-3-iodocepham-4-car- ;~
boxylate, ~-nitrobenzyl 7-phenylacetamido-3-methyl-3-iodocepham-4-car~
boxylate, and trichloroethyl 7-methoxy-7-phenoxyacetamido-3-methyl-3-iodo-cepham-4-carboxylatè

Methyl 7-Phenoxyacetamido-3-Methyl-3-Iodocepham-4-Car~oxylate,l' :
(R = ~OCH2, R2 = H, Rl = CH3) from ~ ethyl 3-Phenoxyacetami-' doazetidinone-l-Isopropenyl Acetate~-4-Disu1fidej 4-(R = ~OCH

R = H, Rl = C~3), using Sulfenyl'Iodides-Iodine-~!ater -'~ 2-Mercaptobenzothiazole (138 mg., 0.83 mmoles) and~io-dine (4Z7 mg., 1.68 mmoles) were added to a stirred solution of -sym-(methyl 3-phenoxyacetamidoaæetidinone-1-isopropenyl acetate)~
4-disulfide (200 mg., 0.28 mmoles) in methylene chloride (15 ml) and the mixture stirred at room temperature for 15 mins. Water (15 ml) was then added and the reaction mixture stlrred over-night at room temperature. The organic layer was separated, dried over magnesium sulfate, filtered and concentrated. The , nmr spectrum of the residue showed the presence of about 80% of the 3-iodocepham.
' - - 27 -- - 9L0~i789~
- In a similar manner using any of the thio-compounds such as thioacetamide, thioacetanilide, thiourea, N,N'-dimethyl-thiourea, N,N'-diphenylthiourea, t-butylmercaptan, isopropyl~
mercaptan, thiophenol, ~-chlorothiophenol, ethyl 2-mercaptoace-~tate, 2-mercaptobenzoxazole, 2-mercaptobenzimidazole, 2-mercap-tothiazolene, triphenylmcthylmercaptan, benzylmercaptan, di-methyl disulfide, dibenzyl disulfide, di-t-butyl disulfid~, di- ;
-tolyldisulfide, thioacetlc acld and~thiobenzoic acld, and the foll o W i D g compounds;
10~ (benzhydryl 3-phenoxyacetamidoazetidinone-i-~isopropenyl-acetate)-4-disulfide, sym-(methoxymethyl 3-phenoxyacetamidoazetldinone-1-isopropcnyl-acetate)-4-disulfide, and -(benzyl 3-phenylacetamidoazetidinone-1-isopropenylacetate)-~
- . ...
" ~ 4-disulfide, it is possible to obtain;
` benzhydryl 7-phenoxyacetamido-3-methyl-3-iodocepham-4-carboxy-late, methoxymethyl 7-phenoxyacetamido-3-methyl-3-iodocepham-4-car- -~ ~ boxylate, and '~ 20 benzyl ~-phenylacetamido-3-methyl-3-iodocepham-4-carboxylate.

- EXAMPLE 17 ` -~
:. - .: , ~
~qethyl 7-Phenoxyacetamido-3-Methyl-3-Iodocepham-4-Carboxylate,l ::
(R - ~OCH2, Rl = CH3, R - H ) from Methyl 2-O.Yo-3-(2-Phenoxy~
acetamido)-4-(Benzothiazol-2-yl)Dithio-a-Isopro~enylaæetldin-l-Acetate, 5 (R = ~OCH2, Rl = CH3, R?a ~, X-R3 = S ~ ~

A mixture of methyl 2-o~o-3-(2-phenoxyacetamido)-4-(benzothiazol-2-yl)dithio-a-isopropenylazetidin-1-acetate ` -(5.2 g., 0.01 mole) and iodine~3.0 g., 0.012 mole) in methy-lene chloride (200 ml) was stirred overnight~16 hrs) at ~ ~7~39Z

ambie~t temperature. The dark red reactio~ mixture was washed with aq~eous sodium thiosul~ate (twice), then water (twice), and dried over magnesium sul~ate with decolorising charcoal.
The light yellow Yiltrate was concentrated to a foam which was extracted with ether. The ~iltered ether solution on concen-tration gave 4.8 g.(97%) o~ the methyl 7-phenoxyacetamido-3-methyl-3-iodocepham-4-carboxylate as an almost white foam. The compound (2.8 g) was purified by gradient elution chromato-graphy on sili~a gel (Mallinkrodt CC-7, 150 g) using hexane:
ether (2:1) ~ ether as the eluants. Tbe compound was isolated (2 g~ as a pale amorphous yellow solid, m.p. 73-76~ (becomes a glass) and melts at 116-120. An accurate high resolution mass spectral analysis gave a measured parent peak of 490.0069, while that calculated for C17HlgN205I127S32 is 490.0060.
The nmr (CDC13) spectrum: ~7;82 to 6.92(m, aryl pro-tons and NH); 5.8(~, C7-H); 5.42(d, J = 4~z, C6-H); 4.95(s, ; C4-H); 4.70(s, - OCH2); 3.87(s, -COOCH3); 2.98(q, J = 15Hz, C2-CH2~; 2.22(s, C3-CH3) are consistent with the assigned ; structure.
,~

Methyl 7-Phenoxyacetamido-3-Methyl~3-Iodocepham 4-Carboxylate,l ~ =~OCH2, Rl =CH3, R2 =H) using Iodine (one atomic equivalent) -When methyl 2-oxo-3-(2-phenoxyacetamido)-4-(benzothia-zol-2-yl)dithio-a-isopropenylazetidin-1-acetate (0.53 g, 0.001 moles) was reacted with iodine (0.13 g, 0.0005 moles or 0.001 g atom) in methylene chloride (25 ml) and the product worked up as described in Example 17,essentially the same results were obtained. The products ~rom Examples 17 and 18 were identical (nmr and ir spectra and tlc).

'~ a~7ssz -.
- - - -~ ~ : EXA~IPLF. 19 - ~
~~- Methyl 7-Phenoxyacetamido-3-~Iethyl-3-Iodocepham-4-Carbo~ylate,l R - ~OCH2-, R =CH3, R2 =H) using N-Iodosuccln1mlde Methyl 2-oxo-3-(2-phenoxyacetamido)-4-(benzothia- . :
zol-2-yl)dithio-~-isopropenylazetid1n-l-acetate (203 mg, 0.38 mmoles) was reacted with N-lodosucclnimlde (94 mg 0.416 mmoles) in methylene chloride at ambient temperature.~
; After 4 hrs, an nmr spectrum~of the residue from an aliquot o~ the reaction mlxture showed essentlally startln~ materials.;
- 10 After 3 days, however, the nmr spectrum of the residue in- ~:
dicated the presence of about 28% of the 3-iodocepham.

EXA~PLE 20 :7-Phenoxyacetamido-3-Methyl-3-Iodocepham-4-Carboxylic Acid, 1 _ (R -~OCH2, R = H,~R = ~) from 2-Oxo-3-(2-Pheno~acetnmido)~

(Benzothiazol-2-yl)Dithio-~-Isopropenylazetidin-l-Acetic Acid,5 (R = ~OCH2, Rl= H, R2= H, X-R3= S~
~ ~ S

.
~. A slurry of 2-oxo-3-(2-phenoxyacetamido)-4 (benzothia-zol-2-yl)thio--isopropenylazetidin-1-acetic acid (5.15 10 mmoles) in methylene chloride (200 mls) and bis-trimethyl-silyltrifluoroacet~mide (2.5 6, 10 mmoles) w~s stlrred until .
, - - 3~ - .
' , .

~ J - - 106~892 -~

- ~
' solution was complete (about 10 mins) then lodine (1.5 g, ~ ''~` -' 11.8 mmoles) was added and the mixture stirred overnight at ~- ambient temperature. The reaction mixture was concentrated and~
- . -the residue treated with ethyl acetate (50 mls). The resulting~

- slurry was filtered to separate the~bis-benzothiazoledisulfide, 1.4 g (85ao). The filtrate was treated~with methanol ~3.0 g, 100 mmoles) for 0.5 hrs and then extracted successively with 5~--` aqueous sodium Ithiosulfate (2~x 30'mls),-water~(3 x 30 mls), and saturated brine, dried over magnesium sulfate, and~the fil-`

0 trate concentrated. The-residue (4.~7~g,-99%)-had ir~spectrum (CHC13): I770, 1740-and 1690 cm l;~-~ nmr~spectrum ~DC13): ' ' 2.27(s, 3H); 2.65 and 3.13(ABd, 2~, J - 15Hz); 4.65(s, 2H);

4.90(s, lH); 5.38~d, J = 4Hz, lH); 5.70(q,~J = 4 and lOHz, ~' lHj; 7.3 to 8.3(m.), 7.92(d, J - lOHz, lH); and 10.2(s, lH);~ -- - ~ in agreement wlth the assigned structure.

~ In a similar manner using~
~' 2-oxo-3-(2-phenylacetamido)-4-(benzothiazo:l-2-yl)dithio-~-iso-propenylazetidin-l-acetic acid, and ' ~

2-oxo-3-(2-phenoxyamido)-4-(benzothlazol-2-yl)dithio--isopro-penylazetidin~l-acetic acid, lt is~posslble ~to obtain~
' 7-phenylacetamido-3-methyl-3-iodocepham-4-carboxylic ~ acid and - 7-phenoxyamido-3-methy'l-~-iodocep'ham-4-carboxylic acid. - '' ~XA~PL~
' . ~ -7-Phenoxyacetamido-3-~.~ethyl-3-Cephem-4-Carboxylic Acid,12, and . . ~ . , . .-?~Phenoxyacetam _ o-3-~eth~1-3 Cephem 7-Phenoxyacetamido-3~methyl-3-1o~ocepham-~-carboxylic acid (0.9 g, 1.9 mmoles) and bls-trimcthylsilyltrifluoroacet-amide (0.9 g, 3.5 mmo~es) in bcn7,cnc.S10 mls) wore stirred , ' ' '"''' '-~

~ ~6,q~9z .
- until solution was complete. Pyridine (0.5 g, 6,3 mmoles) was-added and the resulting mixture heated under reflu~ for. l hr -, - and then filtered. The filtrate was treated with methanol ~- (o.3 g, 10 mmoles) for 0.5 hrs, and the reaction mixture extrac-ted successively with water (4 x 5 mls) and~saturated brine and - dried over magneslum sulfate, and concentràted. The~lnfrare~
- and nmr spectra of the resulting resldue (250 mg, 40%) was con-- ~ slstent ~or 7-phenoxyacetamido-3-methyl-3-cephem.
- The combined aqueous extracts were layered wlth ethyl -acetate (30 mls), stirred and acld1fled to pH l with conc.
hydrochloric acid. Thè ethyl acetate layer was extracted with saturated brine, dried over magnesium sulfate and concentrated :~. - . . :
to give 400 mg, 60%, of 7-phenoxyacetamido-3-methyl-3-cephem 4-carboxylic acid.
- ~

- - - EXA~IPLE 22 Methoxymethyl 6-Phenoxyacetamidopenicillinate Sulfoxide, 11 Penicillin V sulfoxide (19.2 g, 0.05 moles) and tri-ethylamine (5.2 g, 0.052 moles~ were stirred in methylene - chloride (50 mls~ until~ a pale yellow solution resulted. This~
solution was stirred in an ice bath while chloromethyl methyl ether (4.5 g, 0.055 moles) was added slowly, maintaining the temperature below 8C. There ~as an exo~hermic re~ction, the . ~ :
- ~ _colour of the reaction mixture changed from pale yellow to al-most colourless, and a white sslid (triethylamine hydrochloride) - separated from solution. After stirri~g ~or about 2 hrs, the reaction mixture was extracted with coI~ water (2 x 25 mls), and the pale yellow organic layer dried ov~r ma~nesium sulfate, fil-téred and concentrated to ~ive a thick p~le yellow oil. Cold methanol (50 mls) was added and the mixture stirred in an ice bath ~or 1 hr, by which time a white solid had formed. Filtra-i789Z - -.
tion and drying gave 16.5 g (80%) of the desired ester, m.p.
107-109 C, [~ + 192 (c, 1 1n CHC13?. A second crop of 2.2 g was obtained from the mother liquorj making a total of 18.7 g (91%) of methoxymethyl 6-phcnoxyacetamidopenicillinate sulfoxide.
The ir spectrum tNUjol); 1790,1760,1700,1600 and 1590(sh)cm 1 and nmr spectrum (CDC13); ~8.28(d, lH, J = 10.5Hz, -NH); 7.42 to 6.83(m, 5H, C6H5); 6.2 and 6.3(dd, lH, J - 4.5Hz,C~-H); 5.47 and 5.28(ABq, 2H, J = 6Hz, COOCH2O-, restricted rotation); 5~.1 (d, lH, J = 4.5Hz, C5-H); 4.71(s,~ 1H, C3-H); 4 SS(~s, 2H, ~ ~
-O-CH2-CO-); 3.52(s, 3H, -OCH3);~ 1.75 and 1.27(ss, 6H, em-CH3) are in agreement with the assigned structure.

EXA~IPLE 23 Methoxymethvl 2-Oxo-3-(2-Phenoxvacetamido)-4-(Benzothiazol-2-yl)-Dithio-~-Isopropenylazetidin-l-Acetate, 5 (R = ~OCH2, Rl=CH3OCH2, --R2 H X R3 S ~

-A mixture of 2-mercaptobenzothiazole (3.68 g, 0.022 ~, . .
~:~ moles) and metho~ymethyl 6-phenoxyacetamidopenicillinate sul-~- foxide (8.4S g, 0.02 moles) in pu~rified dioxane (100 mls) was - . O
heated under reflux for 6 hrs in an oil bath maintained at 120 .
~ - .
- 20 The reaction mixture was taken to dryness, the residue taken up in chloroform, treated with decolorising charcoal, filtered and concentrated. The residue was triturated with methanol-~ether, filtered and dried when 4.0 g of an electrostatic white posder, m.p. 121-123 was obtained. The ir spectrum (Nujol);
3400,1780,1750,1680,1520cm 1 and nmr spectrum (CDC13): ~8.0 to
6.85(m, 9 aryl protons and -~H); 5.70 to 5.15(m, ~-lactam pro-~ CH2 tons, CH and -COOCH2O-); 5.0(s, CHCOO); 4.55(s, OCH2CO);
3.43(s,-CH2OCH3) and 2.0(s, ~ ) were consistent wlth the assigned structure.

~7~92 ..
~ - EXAMPLE 24 Methoxymethyl 7-Phenoxyacetamido-3-Methyl-3-Iodocepham-4 -;~
~ Carboxylate, 1 (R = ~OCH2, Rl= CH3OCH2 , R2 = H) from ~lethoxy-:
~- methyl 2-Oxo-3-~2-Phenoxyacetamido)-4-(Benzothiazol-2-yl)Di-thio-~-Isopropenylazetidin-l-Acetate, 5 (R= ~OCH2, Rl=CH3OCH2 R~HL~X-~3- S ~

A mixture of methoxymethyl 2-oxo-3-(2-phenoxyacetami-do)-4-(benzothiazol-2-yl)dithio-~- isopropenylazetidin-l-ace-tate (0.4 g, 0.0007 moles) and lodine (0.18 g, 0.0007 moles~ ln methylene chloride was stirred~at ambient temperature for 3.5 -~ hrs (by which time the reaction was found to be complete). The : , ' ` . - :
reaction mixture was washed with~aqueous sodium thiosulfnte ~2 x lO mls), then water (2 x 10 mls) and dried over m~gnesium . .. , .. .. . . - . ................................................ . .
sul~ate. The filtered solution was concentrated and th~ resi~
due extracted with ether (to remove most o~ the lnsoluble ben- -zothiazole component). The ether on concentration gave the desired compoùnd, 0.34 g, (96%). The nmr spectrum (CDCl );
~- - - 3 ~7.92 to 6.92(m, aryl protons and -~H); 5.80 and 5.61(dd, C7-H);
:
- 5.45 to 5.32(m, C6-H, and COOCH~O); 4.89(s, C4-H)-;

4.62(s, -O-CH2-CO); 3.52(s, CH2OCH3~; 2.92(ABq, J = 15~Iær C2-CH2); 2.22(s, C3-CH3) is consistent with the assigned . . .
- structure.

, ~ .

Methoxymethyl 7-Phenoxyacetamido-3-Meth~1-3-Cephem-~-Carboxv-late by the Dehydroiodination of ~ethoxymethyl 7-Phenoxyace-~
tamido-3-Methyl-3-Iodoce~ham-~-C~rboxylate, 1 (R = ~OClI2, -R = CH3OClI2, ~ = H
~ . . .

- ~ Y

~0678~Z

When methoxymethyl 7-phenoxyacetamido-3-methyl-3-iodo-; cepham-4-carboxylate was dehydroiodinated by the process des-cribed in Example 13, an about 70~ yield o~ the 3-cephem was obtained as estimat~d from the nmr spectrum.
.

Methoxymethyl N-Methoxymethyloxycarbonylampicillin Sulfoxide,8 from Ampicillin Sulfoxide, 7 .

A mixture o~ ampicillin sulfoxlde (14.6 g, 0,004 moles) and triethylamine (9.7 g, 0.096 moles) in methylene chloride (125 mls) was stirred until solutlon was complete (approximate-ly 1 hr). This solution was then stirred in an ice bath while chloromethyl methyl ether (7,1 g, 0,088 moles~ w~s added slowly in the presence o~ a slow stream O:e carbon dioxide~ The reac-tion mixture tContaining solids) was stirred an additional ~ hr in the ice-bath and a further 1 hr at room temperature in the continued presence o~ the carbon dioxide stream. The reaction mixture was then cooled well and filtered. The resulting solid was washed with water (2 x 50 mls) and then with ether and dried, giving 8.7 g (43.7%) of the methoxymethyl N-methoxy-- 20 methylcarbamoylampicillin sulfoxide, m.p. 178-180 . Recrystal-lisation ~rom methylene chloride-ether raised the m,p, to 186-O

Analysis: C H N S
Calc'd ~or C21H27N3SO9 50.69 5.47 8.44 6.45 Found " " 50.73 5.40 8.17 6.50 The ir spectrum (Nujol~; 3350,1780,1740,1710,1700(sh) 1675(sh), 1660,1520cm and nmr sp~ctrum (DMSOd6); ~8.22(d, 2H,two -NH-), 7.45(brs, 5H, C6 ~ ); 6.0 and 5.85(dd, J ~ 4Hz, C6-H); 5.55 to 5.17(m, 6H, C5-H, -CHC0, and two -OC 20-) 4.52(8, lH, C3-H); 3.42 and 3.35(~6, 6H, two -OCH~); 1.5 067~9Z
.

and 1.17(ss, 6H, gem dimethyl) are in a~reement with the assig~
.
ned structure.
From the combined organic filtrates o~ this reaction, : 6. 5 g, (33~o) of a solid was isolated. The ir and nmr spectra .. ..
of this material were consistent with it being methoxymethyl ~` ~ ampicillin sulfoxide. ; ~ - -EXA~PLE 27 ~ - ~
.
. ~ . - - . . . . : . -Methox~methyl 2-Oxo-3~ lethoxymethyloxycarbonylamino Phenyl-acetamido)-4-(Benz.othiazol-2-yljDithio-~-Isopropenylazetidin-l-, , - , . . -. ~ ................. . . ..
;10 ~Acetate,S ~R-~CHtN'HCOOCH20CH3), Rl=CH3OCH2,R2=H,XR3=-S 4 ~ ]

- A mixture of 2-mercaptobenzothiazole (0.22 g, 0.00125 moles) and methoxymethyl ~-methoxymethyloxycarbonylampicillin sulfoxide (0.6 g, 0.00125 moles) in purified dioxane (65 mls) was heated under reflux for 16 hrs in an oil bath maintained O
- at 130 C. The reaction mixture was then taken to dryness. The product (0.7 g, 93%) was separated from unreacted material by - - eXtraction with an excess of ethér-the product being soluble.
, The product forms a glass at 60 65 and melts at about 120 C. -The ir spectrum (Nujol): 3350 a~nd 1790 to 1660(multlplets~cm 1 and nmr spectrum (CDC13): ~7.93 to 7.20(br multiplets, aryl - protons); 6.52(d, NH); 5.6 to 4.9(m, 10H); 3.39(s, two C~
_-O-CH3); 1.90(5, ~cH2) are consistent with the assigned structure. -. . :

;: . ' -) --- ~6 -.. . .. ... ... .

~06789Z
~ EXA~PL~ 28 ~ ~ , - : -~' ethoxymethyl 7~ ethox~methyloxycarbonylamino)Phenylaceta-amido-3-1Iethyl-3-Iodocepham-4-Carboxylate,l !R=~CH(NHCOOCH20CH3') . . ~
~ , ,, Rl = CH30CH2~,R2 = H] '~
- . . . . .
:-. ~ : :
~ A mixture of methoxymethyl 2-oxo-3-t~-methoxymethyl-.
~ oxycarbonylamino phenylacetamido)-4-(benzothiazol-2-yl)dithio-' - . , ~.
isopropenylazetidin-1-acetate;~700 mg,;l.12 mmQles) and io-dine (302 mg, 10.4 mmoles) in methylene chloride (70 mls) was ~ . ~ . : . . . ~
~ , stirred at ambient temperature. The reaction was found to be `~ ~10 complete after about 3 hrs. The reaction mixture,v:as washed . .
; 'with aqueous sodium thiosulfate (twice), then water (twice) and the organic layer dried over magnesium. Concentration of the iltrate gave 700 mg o~ a light~brown foa-m whose nmr-spectrum '~
showed the presence of about 6070 of the 3-iodocepham, charac-.: . . . .
terised by the C3-CH3 singlet at ~2.2 and the C2-CH2 A~quartet " ' ~ at about ~2.85.

. ~ . . . . .
' EXA~IPLE 2g Iethoxymethyl 7-a-(~lethoxymethyloxycarbon~lamino)Phenylaceta-amido-3-Methyl-3-Cephem-4-Carboxylate and Cephalexin 9 ~ hen methoxymethyl 7-~-(methoxymethyloxycarbonylami-~no)phenylacetamido-3-methyl-3-iodocepham~4-carboxylate was - ~ heated with pyridine in benzene for l hr and the reaction work-, ed up as described in Example 13, metho~ymethyl 7-~-(methoxy-methyloxycarbonylamino)phenylacetamido-3-methyl-3-cephem-~-car-boxylate was the product as shown from the nmr spectrum and a thin layer chromato~ram usin~ a~reference sample made from .cephalexin by the method described in Example 26.
The compound was readily converted to cephalexin by ' treatment with aqueous acids such as hydrochloric acid, sul- -;: - 37 -789Z ~ -.
furic acid, ~ormic acid, methanesulfo~ic acid and tri~luoro_ acetic acid, followed by adJustment of the pH to about 4.5, to precipitate the cephalexln. A convenient purification step is to isolate the salt such~as, for example, cephalexin tri-~luoroacetate, by addition of solvents such as ether to a solu-- .
- ~ tion oi the title compound in the minimum amount o~ trifluorD-~ ~ acetic acid after solution is~complete. ~ ~

- , .
6-Phenoxyamidopenicillanlc Acld Sulfoxide ;`~ 10 - A slurry o~ 6-aminopenicillanic acid sulfoxide (23.3 g 0.1 mole~ in water (250 mls) was cooled to 0 to 5 C and then - treated with aqueous potassium hydroxide (2N) until a clear . .
~- solution was obtained and the pH of the solution reached 8. -The resulting solution was diluted with tetrahydrofuran(250 ml).
.
A solution of phenyl chloroformate (23.5 g, 0.15 mole) in tetrahydrofuran (100 mls), and an aqueous solution o-f potas-sium hydroxide (2N) were added separately at such a rate as to maintain the pH of the reaction mixture at between 7.5 and 8.5.
After completion of the addition and when thepH had stabilized ~ 20 at 8 for lS mins, the reaction mixture was concentrated to ; o~e-halP its volume. The aqueous concentrate (pH 8.7) was ex-tracted with ethyl acetate (discarded), then layered with ethyl --- acetate (500 mls) and the pH of-the mixture lowered to 2 with-~
aqueous hydrochloric aGid (611). The aqueous laycr was furthor extracted with ethyl acetate (200 mls) and thc combincd ethyl acetate extracts dried over magnesium sulfate, filtered and concentrated. The residue (23.6S g, 67~o) had m.p. 158-167 (decomp.); ir spectrum (Nujol): 3400,1800,1750,1720 and - , 1530cm ; nmr spectrum (D~ISOd6): ~1.30(s, 3H); 1.67(s, 3H) 4,48(s, lH); 5.53(d, J = 4.5~ l); 5.80(q, J - 4.5 and 9HY"

, _ 3~ .

~6~6789Z - -, - lH); 7.0 to 8.3(m, ~X); and 8.1(br, s, lH). - A sample recrysta-llised from methanol had m.p~ 175~1?7(decomp.).
'~ . . ' ' . . ' ' ' :

EXA~SPLE 31 ~~

Methyl 6-Phenoxvamidopenicillanate Sulfoxide ~-~ - A solution of 6-phenoxyamidopenicillanic acid sulf-oxide (13.5 g)lin tetrahydrofuran (200 mls) at O to 5 C was - treated with a solution of diazomethane in ether until evolu-tlon of nltrogen ceased and the yellow colour pe~rsisted for 0.5 hr. Concentration gave the title compound`(14.0 g, .~lOO~o)~

~10 m.p. 50-70 ; ir spectrum (CHCl~); 3400jl800,I750,1500 and ~ . .
~ 1480cm 1; nmr spectrum (CDC13): ~1.20(s, 3H~ 1.73(s, 3H);
.
- 3.37(s, 3H); 4.72(s, lH); 5.13(d, J~= 4.5Hz, lH); 5.83(q, ~- -J = 4.5 and llHz, lH); 6.80(d, J = llHz, lH)~, and 7.1 to ; 7.7(m, 5H3~

Methyl Z-Oxo-3-(Phenoxyamido)-4-(Benzothiazol-2-yl)Dithio-~-Iso-- . ~ . .
propenylazetidin-l-Acetate,5~(R = ~O,Rl = CH3, X-d3 = -S

A solution of methyl 6-phenoxyamidopenicillanate sul~-oxide (11.0 g, 30 mmoles) and 2-mercaptobenzothiazole (5.5 g, -~
.. . .
20 ~ 33 mmoles) in dioxane ~180 mls) was heated under reflux for 6hr.
Concentration gave a residue ~(16.1 g), a portion (13.6 g) of which was chromatographed on ~allinckrodt Silicar CC-7 (300 g, 200-325 mesh) using benzene-ethyl~acetate mlxtures. Elutlon ;-with a:l and 3:2 benzene-ethyl acetate mixtures gave the title compound(g g) of sufficient purity for further transformations.
The compound had an ir spectrum (CNCl~): 1780 and 1750cm 1;
- ' nmr spéctrum (CDC13): ~l.90(s, 3H); 3.73(s, 3H); 4.93(s, lH);

.

11. ~67892 - - -5.07(brs, 1~); 5.20(brs, lH), -5.40(q, J = 5 and 8Hz, lH), ,''S.58(d, J = 5Hz, lH) and 6.9 to 8.1(m). , - . . .
~ -' `- EXAMPLE 33 - - - .
- : :
2-Oxo-3-(Phenoxyamido)-~-(Ben7,othia~ol-2-yl)Dithio--Isopro-penylazetidin-l-Acetic Acid, 5( r= ~0, Rl- H, X-R3 = -S~3 This compound is obtained by he'ating 2-mercaptobenzo- ~
., . . ~:
thiazole with ~-phenoxyamidopenicillanic acid sulfoxide in -dioxane for 6-~rs. -'~

, EXAMPLE 34 Methyl 7 Phenox,~amido-3-~.Iethyl-3-Iodocepham-4-Carb~xylate, 1 O, ~ = CH3,'R = H) .. . : - . - . .
.
~ , ' - A mixture of methyl 2-oxo-~-(phenoxyamido)-4-(benzo-. . - . ~ -. :
"~ thiazol-2-yl)dithio-~-isopropenylazetidin-l--acetate (0.52 g, -~
, 0.00l mole) and iodine (0.25 g, 0.00l mole) in methylene chlor-~' ide (25 mls) was stirred at,àmbient temper,ature for i2 hrs.
~- The reaction mixture was,then washed with aqueous sodium thio~

sulfate (twice) and water (twice~ and'dried over magnesium sul-~fate and decolorising charcoal. The filtrate was concentrated to a yellow foam~(O.7 g)~. The '~oam~was e~tracted with ether 20 (three times) and the ether solution conce,ntrated to give 0.4 g (85~) of the title compound as a pale yeIlow foam_ The com-pound was further purified by gra~lent eLution column chroma~
tography using Mallinckrodt Silic~ CC-7 and hexane:ether (2:1)~
~ ether. It was obtained as a,pale yel'l-~ foam, nmr spectrum`
(CDCl3): ~7.35(br d, SH, C6H5), 6.48~d,, lH, -NH-, exchanged with D20); 5.62 and 5.4(dd with a superlmposed s at ~5.43, 2H,~
~-lactam protons ~the pattern c~anges to a quartet on D2O ex-' ;' ~ 789~

.
.
. change~); 4.95(s, lH, C4-H); 3.83(s, 3H, COOCH3)'; 3.02(AB~

- J = 15Hz, 2H, C2-CH2); ~.22(s, 3H, C3-CH3)'.
. ~-~ . - ..
' .In a similar manner using~
trichloroethyl 2-oxo-3-(2-phenoxyacetamido)-4-(benzothiazol-2-yl)dithio-~-isopropenylazetidin-l-acetate,' ~ ~:
~ trichloroethyl 2-oxo-3-(2-phenylacetamido)-4-(benzothiazol-2- :
- ~ , . , "
yl)dithio-~-isopropenylazetidin-l-acetate, '~
methoxymethyl 2-oxo-3-(2-phenoxyamido)-4-(benzothiazol-2-yl)-;~ dithlo~ sopropenylazetidln-l-acetate, ~: '10. benzyl 2-oxo-3-.~2-benzyloxyamido)-~-(benzothiazol-2-yl)dithio-a-isopropenylazetidin-l-acetate, :...... ~trichloroethyl 2-oxo-3-(7~-tFichloroethoxyamido)-4-(benzothla- ':
- ~ zol-2-yljdithio-~-isopropenylazetidln-1-acetate,~
methyl 2-oxo-3-2-phenoxyacetamido)-4-acetimidoyldithio-~-iso-- propenylazetidin-`l-acetate, ~
~ methyl 2-oxo-3-(:2--phenoxyacetamido~-4-N-phenylacetimldoyldi-~ thio-a-isopropenylazetidin-l-acetat;e~.and, ~.' methy]. ~-oxo-3-C2-phenoxyacetamido~-4-anili.nothio-~-isopro~
~, penylazetidin-l-~acetate 2Q it is possible to obtain the following compounds~
.-,.,v, .r .: ~ trichloroethyl'7-phenoxyacetamido-3-methyl-~-iodocepham-~-car~
boxylate~
trichloroethyl 7-phenylacetamido-3-methyl-3-iodocepham-4-car-.'~ boxylate, methoxymethyl 7-phenoxyamido-3-methyl-3-io.d~cepham-4-carboxy- :

: late, - :
: ~ benzyl 7-benzyloxyamido-3-methyl-'3-io.doc~pham-4-carboxylate, .~' trichloroethyl'7-trichloroethoxyamido-3-met-hyl-~-iodocepham-4-. . carboxylate, and ' ' ': ~

methyl 7-phenoxyacetamido-3-methyl~-1odocepham-4-carboxylate. -~' . :

- ' - ~ r~

`` : IL~671~39z : . ..... .
: EXAMPLE 35.
'' ' :' -- ~Iethyl 7-Phenoxyacetamido-3-~lethyl-3-Iodocepham-4-Carboxylate,.

1, (R = ~OCH2-, R.- H, R = CH3) from ~lethyl 3-Phenoxymethyl-4, : .
.~ 5~Dithia-2,7-Diazabicyclo[~,2,010ct-2-Ene-8-One-7-Isopro~enyl - acetate, 2 (R = ~OCH2-, R2= H, Rl= CH3) using Disulfides--- . .
. Iodine-Water A mixture of methyl 3-phenoxymethyl-4,5-dith1a-2,7-dia7.abicyclo[4,2,0]oct-2-ene-8-one-7-isopropenylacetate .~
100 mg., 0.253 mmoles), dibenzyl disulfide (47 mg.,O.2 mmoles) and iodine (193 mg., 0.76 mmoles~ in methylene chloride (lO ml):
.
was stirred with water ~10 ml) at amblent temperature~for 16 hrs. The organic layer was dried over magnesium sulfate, ~ : . . . . . .
- . i'iltered and concentrated. The nmr spectrum (CDC13) of the ~.
~ : . product indicated over 85% of the 3-iodocepham to be present.
: Exactly similar reactions werè run using the-following ~ disulfides in place of dibenæyl disulfide, The yield of the ~ . - ~ .
. 3-iodo~epham in ~ach case was estimated as better than SOZ.
: . Dimethyl dis-llfide - ~:
: 2,2'-Dithiobis~benzothiazolé) .
. EXAMPLE 36 Methyl 7-Phenoxyacetamido-3-,'~.1ethyl 3-Iodocepham-4-Carboxylate, 1, (R = ~OCH2-, R = H, R = CH3) ~rom ,~lethyl 3-Phenoxymethyl-4,~
5-Dithia-2,7-Diazabicyclo~4 9 2,0]0ct-2-~ne-~-One-7-Isopro~enyl-.

acetate, 2 (R = ~OCH2-, R2= H, Rl=CH3) using Thioacids-Iodine-Water __..

' A mixture o~ methyl 3-phenoxymethyl-4,5-dithia-2,7- .

diazabicyclo[4,2,0]oct-2-ene-8-one-7-isopropenylacetate(100 mg., :

3~ 39Z - - ;

o.253 mmoles), thiobenzoic acid (53 mg., 0.38 mmoles) and ~ ~
. .
; iodine (193 mg., 0.76 mmoles) in met-hylens chloride (lO ml) ..
was stirrsd with water (10 ml) at ambient temperature for 16hrs.
The organic layer was dried over magnesium sulfate~ filtered, and concentrated. The nmr spectrum (CDC13) of the product in-dicated over 85% o~ the 3-iodocepham to be present.
When the reaction was repeated as above, using thio-acetic acid in place of thiobenzoic acid, low ylelds (about ~ -~20~) of the 3-iodocepham were obtained.

~ ~-A~PI~ ~7 ethyl 7-Phenoxyacetam1do-3-Methylceph-3-em-~-Carboxylate from Methyl 7-Phenoxyacetamido-3-Methyl-3-lodocepham-4-Carboxylate.

-: :
1, (R = ~OCH2-, ~2= H, R = ~H3), using Pyridine in Benzene ~ --- A solution of methyl 7-phenoxyacetamido-3-methyl-3-iodocepham-4-carboxylate and pyridine in bsn~ene was heated O ' :
~; under reflux, in an oil-bath maintained at 90 .- Periodically - aliquots of the reaction mixturs were removed and the progress~
: . . . -.~
of the reaction followed by analysing the nmr~spectrum~of the , -residue.- The 3~iodocepham:in the mixturs is characterisèd by ;

the C4-H singlet-at ~4.9, the C6-H doublet at ~5.38 and the C2-CH2 quartet at ~2095; the ceph-3-em is characterised by its C6-H doublet at ~5.05 and its C2-CH2 doublet at ~3.35. ;~

Any ceph-2-em produced is easily detected by its C3-CH3 sing-.:
let at ~1.92 and its C2-H signal at 66.1. In all our ex-periments using pyridine as the base there were no detectable amounts of the ceph-2-em isomer produced. The following table~
summarizes the results of experiments in which the relative amount of pyridine was varied.

'''''' '~

~6789~
.
- . -~ ~ TAELE 1 :
Dehydroiodination of 3-Iodocepham~uslng P~ridine in Benzene No Mole Ratio of Pyridine Time of Reflux Yield of Ceph-3-em(~

1. 2.S equivalents 0.5 hr 4 2. 2.5 " 1.0 hr 60 3. 2.5 " ;~l.S hr ~ 67 4. ~ ~5 equivalents 0.5 hr ; ; 50 5. 5 ~ " 1.0 hr ~ 66 6. 5 ~ 1.5 hr ~ 80
7. 5 ~ 3.0 hr ~100
8. 10 equivalents ~ ` ~.5 hr ~60
9. lQ ~" - 1.0 hr ~100 `
10. 10 " 1.5 hr 100 * There was no detectable trace of any ceph-2-em isomer in . ~
any of these experiments. ~ -EXAMPL~ 38 Methyl 7-Phenoxyacetamido-3-3fethylceph-3-em-4=Carbo ylate from Me~l 7-Phenoxyacetamido-3-~lethyl-3-Iodocepham-4-Carbox~ate,`

; 1 (R = ~OCH2-, R2= H, Rl= CH3) using Pyridine alone - 20 -- Methyl 7-phenoxyacetamido-3-methyl-3-iodocepham-4-car~

- boxylate (100 mg) was dissolved in pyridine d5 (O.S ml)~and the reaction monitored by running an nmr spectrum on the sample " ,. . .
periodically. After about 15 mins at ambient temperature there~
was about 50S conversion to the ceph-3-em, and after 2 hrs the reaction was complete. ~he nmr spectrum did not chan~e after a 24-hour period and again no detectable amount of the ceph-2-em isomer was obscrved.

.

:106'7~92 - . . ` ~ ~
.

~fethyl 7-Phenoxyacetamido-3-~Iethylceph-3-(and -2-)em-9-Carbox~
late from Methyl 7-Phenoxyacetamido-3-~lethyi-3-Iodocepham-~-Carboxylate, 1 (R = ~OCH2-, R2= X, Rl- CH3~ using Hunig's Base A mixture o$ methyl 7-phenoxyacetamido-3~methyl-3~iodo-- cepham-4-carboxylate (200 mg.~ 0.395 mmoles) and diisopropyl---ethylamine ~510 mg., 3.95 mmoles) ln benzene~d6 (1 ml) was heated under reflux for 1 hr. The reaction mixture was washed with hydrochloric acid (2N solution), then water, and dricd.
~The nmr spectrum showed complete reaction but a mixture of about 40% of the ceph-2-em and 60% of the-ceph-3-em compounds.

EXAMPLE 40 ;~

Methyl 7-Phenoxyacetamido-3-Methylceph-3-(and -2-)em-4-Carboxy-late from Methyl 7-Phenoxyacetamido-3-.llethyl-3-Iodocepham-4-Carboxylate, 1 (R = ~OCH2-, R2= H, RL=~CH3)~using DBU~and DBN

. _ _ ,~ . .
~-A mixture of methyl 7-phenoxyacetàmido-3~methyl-3-iodo-cepham-4-carboxylate (100 mg. 7 0.2 mmoles) and 1,5-diazsbicy-:clo[5,4,0]undec-5-ene (DBU, 300 mg., 2.0 mmoles) in benzene d6 ~ (1 ml) was left at ambient temperature ior l.S hrs. The reac- -tion mixture was washed with hydrochloric acid (2N solution), : .
then water, and dried. The nmr-spectrum showed about 75%
reaction with a mixture of ceph 2-em and ceph-3-em being formed. ~ ~
When l~5-diazabicyclo[~3~olnon-5-ene (DB~) was substi-tuted ~or DBU in the ahove reaction, and with a re~ction time of 2 hrs at ambi~nt temperature, the reaction was essentially complete, the product consistin~ o~ a mixture oi the ceph-2-em and ceph-3-em isomers in the ratio oi about 3:7.

.. .
,.

~)6~89Z

- . ~ ' . ~
ethyl 6-Phenoxyacetamido-2-~ethyi-2-Iodomethylpenam-3-Carbo~y-lats, lA ~R = ~OCH2-, R = CH3, R = H) and'Methyl 7-Phenoxyacet-' amido-3-~Iethyl-3-Iod'ocepham-4-Carboxylate, 1 (R = ~OCH2-, Rl=

, CH3, R = H) from Methyl 2-Oxo-3 (2-Phenoxyacetamido)-4-~Benzo-~
_. -thiazol-2-yl)Dithio-a-Isopropenylazetidin-l-Acetate, 5 (R=~'OCH2, Rls CH3, R2= H , X-R3= -S-< ~

~ A mixture of methyl 2-oxo-3-(2-phenoxyacetamido)-4-benzoth1azol-2-yl)dithio-~-isopropenylazetidln-l-acetate (5.0 g., 9.5 mmoles) and iodi,ne (1.~ g., 14.2 mmol,es) in methylene ~

.
, chloride (100 ml) was stirred at amhient temperature for 16 hrs.
, ~ , . . .
The reaction mixture was then washed quickly with an aqueous , - soidum thiosulfate (5%) solution (twice), and the methylene, ~; chloride layer dried over magnesium sulfate and taken to drynéss ~

, ~ to give 5.2 g of a yellow foam. ~ ~

- 'The material was chromatographcd on a ~allinkrodt SiliCar CC-7 (350 g.) column u~ing ether as-the eluant, and , collecting fraction of about 5 mls. The appropriate fractions ~ were combined according to their thln layer chromatograms. ~;
`~ 20 Fractlons 5 to 22 were combined and concentrated to~
~give 1.3 g. o~ a yellow foam, whose nmr spectrum indicated a ' mixture of the ben~othiazole disu'lfide, the 3-iodocepham and the 2-iodomethylpenam, characterised by its ~-lactam multlplet at~
about ~5.9 to 5.65,C3-H singlet at ~4.9, -OCH2CO- sin,glet at ~4.6, -CH2I at ~4.45, -COOC~I2 singlet at ~3.8, and -CH3- singlet at ~l.fi.
i Fractions 23 to 34 wcre combined and concentrated to give 1.2 'g. o~ a yel1ow ~oam consistin~ o~ the 3-lodocepham ~nd ,, , - 46 -,. . . .

!
.
- ~067892 -the 2-iodomethylpenam, in the ratio o~ about 7 3~
Fractions 35 to 65 were combined and concentr~ted to .~
giYe 2.4 g. of a p~le yellow ~oam, consisting o~ the 3-iodo-~
~: cepham, with traces (about 5%~ of the 2-iodomethylpenam.
::

Me~hyl 2-Oxo-3-Phenoxyacetamido-4-Acetimidoyldithio-a-Isopropenylazetidin-l-Acetate, 5 (R = ~OCH2CONH9 Rl = CH3, R2 _ H, R3 = CH3, R4 _ H) and Methyl Penicillin V~
A mixture of methyl penicillin V sulfoxide (0.38 9., 0.001 mole) and thioacetamide (0.08 9., 0.001 mole)~in purified -dioxane (25 ml) was heated und r reflux wi~th stirring for S ~hrs, in an oil-bath maintained at 120C. The clear reaction mixture was concentrated under vacuum to a brown foam. The ir spectrum (CHC13) showed s-trong sharp singlets at 1780, 1745, and -1700 ; ~ cm 1 with weaker absorptions at 1600 and 3400 cm l~. The nmr spectrum (CDC13) indicated a mixture containing methyl 2-oxo-3-phenoxyacetamido-4-acetimidoyldithio-~-isopropenylaz~etidin-1-~: - . , , , - . . .
acetate, 5, as the main product characterized by signals at 65.22 and 5.1 ( ~H2), 2.55 ( ~ CH3), and 1.92 ( ~ cH2)~
CH3 ~ NH ~ CH3 -~ 20 among others9 and methyl penicill~n V (estimated at 20% and ~ ~
confirmed by thin layer chromatogra-phy characterized by its ~--dimethyl signals at ~1.65 and 1.~. In addition, there were trace amounts of methyl 4-phenoxyacetamidoisothiazol-3-one-1-a-isopropenylacetate, characterized by its signals at~ca. ~9.2 and 8~.83.

Methyl 2-Oxo-3-Phenoxyacetamido-4-(N-Phenylacetimidoyl)Dithio-~-Isopropenylazetidin-l-Acetate, 5 (R - ~OCH2CONH, Rl - CH3, R ~ H, R _ CH3, R
.
A mixture of methyl penicillin V sulfoxide (0.38 9., O.OOl mole) and thioacetanilide (0.15 g., 0.001 mole) in puri-. .. ... ~ -- 47 ~
.
, .. . . . .: .. . .. . ~ .. ... ~.

- ~L067~9Z

fied dioxane (25 ml) was heated under reflux with stirring ~Qr :`~`
5 hrs in an oi1-bath kept at 120C. The clear reac~ion mixtur~
~ on concentration under vacuum gave a brown foam. The n~r ~ spectrum (CDC13) indicated that the reaction was incomplete7 - ~ about 20% of methyl penicillin V sulfoxide being present, alo~g-; with methyl 2-oxo-3-phenoxyacetamido-4-(N-phenylacetimidoyl)-dithio--isopropenylazetidin-l-acetate characterized by ~5.7 to 5.3 (m, ~-lactam protons),~ 5.2 and~.05 ( ~CH2), 4.92 3 ( CH2 ?. 2.72 ( ~ ~ ) and 1.92 ( ~ CH2) 10~ In a similar manner using solvents such as toiuene, . ~,,~.
dichloroethane, mesitylene, and thioamides such as thiobenz- ~
amide, N-methylthioa~etamide, N-methylthiobenzamide, N-phenyl--~-thiobenzamide, thionicotinamide, thioisonicotinamide, 2-thi-azolethioacetamide and 2-thiazolethiobenzamide~ and penicillin sulfoxides such as trichloroethyl penicillin V sulfoxide, .
- methoxymethyl penicillin V sulfoxide, p-nitrobenzyl penicillin Y sulfoxide, penicillin G sulfoxide9 methoxymPthyl penicillin G
sulfoxide, trichloroethyl pe~nicillin G~sulfoxlde, 6-phenoxy-amidopeniciliin sulfoxide, methoxymethyl N-(methoxymethyloxy-carbonyl)ampicillin sulfoxide, di(methoxymethyl)carbenicillinsulfoxide, and 6-thien-2-ylacetamido-6-methoxypenicillin sulfoxide: various azetidinone disulfides of formula 5 are obtained.
EXAMP~E 44 Methyl 7-Phenoxyacetamido-3-Methyl-3-Iodocepham-4-Carboxylate - from Methyl 2-Oxo-3-Phenoxyacetamido-4-(Aminoimldoyl~Dithio-~-Isopropenylazetidin-l-Acetate, 5 (R - ~OCH2CONH, R = CH3,~
~2 = H R3 ~ NH2. R4 - H) - ~ -The total crude product obtained in Example 43 was dissolved in methylene chloride (5 ml) and stirred with iodine(0.13 ~., 0.00052 moles) at ambient temperature for 16 hrs.

.

1 , ~', ,~.

- 1 ~6 ~ ~ 9 Z . -The reaction mixture was then concentrated to give a b~rown .
foamO The formation of methyl 7-phenoxyacetamido;3-methyl-3 :iodocepham-4-carboxyla~e in this reaction was shown by~com-paring the nmr spectrum of~the crude product with that of ~ authenti~c sample. A thin~iayer chromatogram usin~ an authen~e~
- - sample of-the 3-iodocepham confirmed its presence in the ~::
reaotion~mixture. ~`
~~ ~ EXAMPLE 45 Dehydroiodination of Methyl 7-Phenoxyacetamldo-3-Methyl-3 lO :~ Iodocepham-4-Carboxylate Using Pyridine in ûenzene -~
:~ ~ ; A solution of methyl 7-phenoxyacetamido-3-methyl-3- ~
~ iodocepham-4-carboxylate and pyridine in benzene was heated -'' !
under refluxl in an oil-bath maintained at 90. Perlodically ~ -aliquots of the reaction mixture were removed and the progress :~
. ~ of the reaction followed by analysing the nmr spectrum of~the . ~ ~
: residue. The 3-iodocepham ir. the mixture is char~cterized by the C4-H singlet at ~4.9, the C6-H doublet at ~5.38 and the C2-CH~ quartet at ~2.95i the ceph-3-em is characterized by its~
G6-H doublet at ~5.05 and its C2-CH2~doublet at 63.35. Any 20~ ceph-2-em produced is easily detected by its C3-CH3 singlet at l.92 and its ~2-H signal at:~6.1. In a-ll our experiments :~
: using pyridine as the base there were no detectable amounts of `
the ceph-2-em isomer produced. The following table summarizes~
~ the results of experiments in which~the relative amount of H pyridine was varied.

.

.

.' ~

_ ~9 _

Claims (10)

The embodiments of the invention in which an exclu-sive property or privilege is claimed are defined as follows:
1. The process for preparing a compound of the formula:

wherein R stands for phenoxymethyl and .alpha.-aminobenzyl, and R3O- wherein R3 is lower alkyl, phenyl and phenyl-loweralkyl;
R1 is hydrogen or a cleavable radical, and R2 is hydrogen, which comprises treating a 1,2,4-dithiaz-3-eneazetidinone (2) or a thiazol-2-eneazetidinone (3) of the formula:

2 or 3 wherein R, R1 and R2 are as previously defined with more than one atomic equivalent of iodine or a sulfenyl iodide and iodine in the presence of moisture in a suitable solvent.
2. The process of Claim 1, wherein the starting 1,2,4-dithiaz-3-eneazetidinone is methyl 3-phenoxymethyl-4,5-dithia-2,7-diazabicyclo[4,2,0]oct-2-ene-8-one-7-isopropenyl acetate and the iodocepham compound obtained is the methyl 7-phenoxyacetamido-3-methyl-3-iodocepham-4-carboxylate.
3. The process of Claim 1, wherein the starting 1,2,4-dithiaz-3-eneazetidinone is methyl 3-phenoxy-4,5-dithiaz-2,7-diazabicyclo[4,2,0]oct-2-ene-8-one-7-isopropenyl acetate and the iodocepham compound obtained is the methyl 7-phenoxyamido-3-methyl-3-iodocepham-4-carboxylate.
4. The process of Claim 1, wherein the thiazol-2-eneazetidinone is the methyl 3-phenoxymethyl-4-thia-2,6-diazabicyclo[3,2,0]hept-2-ene-7-one-6-isopropenyl acetate and the iodocepham compound obtained is the methyl 7-phenoxy-acetamido-3-methyl-3-iodocepham-4-carboxylate.
5. The process of Claim 1, wherein methyl 3-phenoxymethyl-4,5-dithia-2,7-diazabicyclo[4,2,0]oct-2-ene-8-one-7-isopropenyl acetate is reacted with thiourea and iodine to yield the methyl 7-phenoxyacetamido-3-methyl-3-iodocepham-4-carboxylate.
6. The process of Claim 1, wherein methyl 3-phenoxymethyl-4-thia-2,6-diazabicyclo[3,2,0]hept-2-ene-7-one-6-isopropenyl acetate is reacted with 2-mercaptobenzothiazole and iodine to yield the methyl 7-phenoxyacetamido-3-methyl-3-iodocepham-4-carboxylate.
7. The compounds of the formula:

1 wherein R stands for phenoxymethyl and .alpha.-aminobenzyl, and R3O- wherein R3 is lower alkyl, phenyl and phenyl-loweralkyl;

R1 is hydrogen or a cleavable radical, and R is hydrogen, when prepared by the process defined in Claim 1 or by an obvious chemical equivalent.
8. The compound of Claim 7 which is methyl 7-phenoxyacetamido-3-methyl-3-iodocepham-4-carboxylate, when prepared by the process defined in Claim 2 or 4 or by an obvious chemical equivalent.
9. The compound of Claim 7 which is methyl 7-phenoxyamido-3-methyl-3-iodocepham-4-carboxylate, when prepared by the process defined in Claim 3 or by an obvious chemical equivalent.
10. The compound of Claim 7 which is methyl 7-phenoxyacetamido-3-methyl-3-iodocepham-4-carboxylate, when prepared by the process defined in Claim 5 or 6 or by an obvious chemical equivalent.
CA229,909A 1975-06-23 1975-06-23 Iodo compounds Expired CA1067892A (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
CA229,909A CA1067892A (en) 1975-06-23 1975-06-23 Iodo compounds
SE7601704A SE7601704L (en) 1975-06-23 1976-02-16 3-IODCEFAMER AND 2-IODMETHYLPENAMER AND METHODS OF PREPARING THE SAME
NL7602157A NL7602157A (en) 1975-06-23 1976-03-02 PROCESS FOR THE PREPARATION OF CEPHALOS SPORINS.
DE19762608969 DE2608969A1 (en) 1975-06-23 1976-03-04 3-HALOCEPHAME AND ITS ISOMERS AND PROCESS FOR THE PREPARATION OF THE SAME
FI760640A FI760640A (en) 1975-06-23 1976-03-11
DK144576A DK144576A (en) 1975-06-23 1976-03-30 IODINE COMPOUNDS AND METHODS FOR MANUFACTURE THEREOF
AT268476A AT343807B (en) 1975-06-23 1976-04-13 PROCESS FOR THE PRODUCTION OF NEW 3-HALOCEPHAMS AND THEIR ISOMERS
NO761353A NO761353L (en) 1975-06-23 1976-04-21
GB20744/76A GB1545251A (en) 1975-06-23 1976-05-19 Process for preparing 3-iodocephams and 2-iodomethylpenams
FR7618804A FR2315505A1 (en) 1975-06-23 1976-06-21 3 IODOCEPHAMES AND THEIR PROCESSING METHODS
CH796176A CH619231A5 (en) 1975-06-23 1976-06-22 Process for the preparation of iodinated derivatives of cepham and of penam
JP51073772A JPS525792A (en) 1975-06-23 1976-06-22 Production of iodo compound
BE168197A BE843278A (en) 1975-06-23 1976-06-23 3-IODOCEPHAMES AND THEIR ISOMERS AS WELL AS THEIR METHODS OF OBTAINING

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA229,909A CA1067892A (en) 1975-06-23 1975-06-23 Iodo compounds

Publications (1)

Publication Number Publication Date
CA1067892A true CA1067892A (en) 1979-12-11

Family

ID=4103405

Family Applications (1)

Application Number Title Priority Date Filing Date
CA229,909A Expired CA1067892A (en) 1975-06-23 1975-06-23 Iodo compounds

Country Status (13)

Country Link
JP (1) JPS525792A (en)
AT (1) AT343807B (en)
BE (1) BE843278A (en)
CA (1) CA1067892A (en)
CH (1) CH619231A5 (en)
DE (1) DE2608969A1 (en)
DK (1) DK144576A (en)
FI (1) FI760640A (en)
FR (1) FR2315505A1 (en)
GB (1) GB1545251A (en)
NL (1) NL7602157A (en)
NO (1) NO761353L (en)
SE (1) SE7601704L (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206361A (en) * 1990-03-08 1993-04-27 Otsuka Kagaku Kabushiki Kaisha Thiazolinoazetidinone derivative

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2143211B1 (en) * 1971-06-24 1975-10-31 Fujisawa Pharmaceutical Co
GB1466599A (en) * 1974-08-07 1977-03-09 Farmaceutici Italia Process for making cephalosporins

Also Published As

Publication number Publication date
NO761353L (en) 1976-12-27
DE2608969A1 (en) 1977-01-13
ATA268476A (en) 1977-10-15
SE7601704L (en) 1976-12-24
FR2315505A1 (en) 1977-01-21
JPS525792A (en) 1977-01-17
FI760640A (en) 1976-12-24
DK144576A (en) 1976-12-24
NL7602157A (en) 1976-12-27
AT343807B (en) 1978-06-26
CH619231A5 (en) 1980-09-15
BE843278A (en) 1976-10-18
GB1545251A (en) 1979-05-02

Similar Documents

Publication Publication Date Title
KR910002098B1 (en) Process for penem compounds
SE405857B (en) PROCEDURE FOR SUBSTITUTING A GROUP IN A 6-RESP 7 POSITION WITH A PENICILLANIC ACID ASSOCIATION OR CEPHALOSPORANIC ACID ASSOCIATION
CA1109859A (en) Thiooxime cephalosporin and penicillin derivatives
CA1067892A (en) Iodo compounds
CA1072564A (en) 4-chloroazetidinone-1-(2&#39;-3&#39;-dichloroisopropyl) acetates and process for preparing same
FI75165B (en) FOERBAETTRAT FOERFARANDE FOER FRAMSTAELLNING AV PENICILLANSYRAKLORMETYLESTRAR.
US4456755A (en) 7-Oxygen analogs of cephalosporins
CA1146538A (en) Process for chemically removing the acyl side-chain from cephalosporins and penicillins
US3968109A (en) Production of 2-(thio substituted)cephalosporin sulfoxides and 2-(thio substituted)cephalosporins
US4675396A (en) 7-Oxo-4-thia-1-azabicyclo(3,2,0)heptane derivatives
US4704385A (en) 3-formamido azetidinone antibacterial agents, their preparation and use
US4943631A (en) Process for cephem compounds
US4422971A (en) Process for the preparation of 6-aminopenicillanic acid-1,1-dioxide
US4091026A (en) Thiazoleneazetidinones from dithiazeneazetidinones
US4771134A (en) Ring-opening process for preparing azetidinone intermediates
EP0397212B1 (en) Process for preparing cephalosporin compounds
CA1071213A (en) Thiazoleneazetidinones from penicillin sulfoxides
US4801720A (en) Azetidinone disulfides and a ring opening process for preparing the same
US4035354A (en) Thioamides of beta-lactam antibiotics
US4006139A (en) 1,2,4-Dithiaaz-3-enes
CA1051008A (en) Thioamides
US5821362A (en) Method of desilylating silylether compounds
CA1063610A (en) Thiazoleneazetidinones from dithiazeneazetidinones
GB2165245A (en) Chemical compounds
CA1115692A (en) Oxygen analogs of cephalosporins